Sentence,class,file
"Neuroimage 100, 75 –90.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
"Epidemiology and outcomes of pediatric traumatic brain in- j u r y .D e v .N e u r o s c i .2 8( 4 –5), 256 –263.http://dx.doi.org/10.1159/00009415216943649 .",Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
"Aging 33, 9 –20.http://dx.doi.org/10.1016/j.neurobiolaging.",OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1089/neu.2008.,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1385/MN:24:1-3:16911831551 .,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1097/01.HTR.0000327252.54128.7c18650764 .,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/ 10.1016/j.expneurol.2007.01.03517368446 .,OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.3171/jns.2006.,OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1017/S135561771000118921070694 .,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1177/088307380935603420332386 .,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1016/j.clineuro.2011.12.,OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1093/brain/awm29418083753 .,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
"7, 63 –85.http://dx.doi.org/10.1146/annurev- clinpsy-032210-10450721219189 .",Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1007/s11682-012-9150-y22399284 .,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1089/neu.2006.23.141217020479 .,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1212/01.wnl.0000305961.68029.5418347317 .,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
"82 (1), 86 –96.http://dx.doi.org/10.1016/j.ijpsycho.2011.04.",OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1016/j.acn.2007.03.00417446039 .,OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1159/00031705820948181 .,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1089/neu.2006.020817518531 .,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.1111/j.1552-6569.2010.00537.,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/10.3174/ajnr.,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.org/ 10.1016/j.neuroimage.2010.05.04920570617 .,OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/19/main.PMC4338205.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/j.nicl.2015.02.003 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
"In short, we registered the WMH maps to the T1 images using the transformation matrix from the registration parameters of skull-stripped FLAIR images to the T1-images that were obtained using Functional MRI of the Brain linear image registration tool ( http://www.fmrib.ox.ac.uk/fsl/fnirt ).",OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
"Next, we normalized the WMH maps non-linearly to the group-speci ﬁc template using the transformation parameters of T1 images to the group-speci ﬁc template obtained from Functional MRI of the Brain non-linear registra- tion tool ( http://www.fmrib.ox.ac.uk/fsl/ ﬂirt).",Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1093/brain/awp25719914928 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.02.01815955494 .,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.02.,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1037/ 0894-4105.15.4.60711761050 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
"Brain 134 (1), 73 –83.http://dx.doi.org/10.1093/brain/ awq34321156660 .",OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
"Psychiatry 70 (1), 9 –14.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.3174/ajnr.A055517698534 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1111/j.1750-3639.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.2214/ajr.149.2.3513496763 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.3233/JAD-2012-12100622869466 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1001/ archneur.1991.005301500610191705796 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.01.01915862219 .,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1136/jnnp.,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
"15 (1), 1 –25.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1002/ mrm.2146118224697 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1212/WNL.57.4.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1212/WNL.57.12.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
"Stroke 46 (1), 262 –264.http://dx.doi.org/10.1161/STROKEAHA.114.00755325395414 .",Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1148/ radiology.201.3.89392098939209 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1177/ 014662167700100306 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/S1474- 4422(02)00190-412849365 .,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1111/j.1751-7176.2007.tb00006.x17917507 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.05.,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1 016/j.neuroimage.2006.02.02416624579 .,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
"Neuroimage 44 (1), 83 –98.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.09.06023032491 .,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
"11, 29. http://dx.doi.org/10.1186/1471-2377-11-2921356112 .",Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/j.bbadis.2011.04.00821549191 .,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1056/NEJMoa02206612660385 .,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.07.05218755279 .,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1056/ NEJMoa07097217978290 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
"http://dx.doi.org/10.1001/archgenpsychiatry.2009.519414714 .Wardlaw, J.M., Smith, E.E., Biessels, G.J., Cordonnier, C., Fazekas, F., Frayne, R., Lindley, R.I., O ’Brien, J.T., Barkhof, F., Benavente, O.R., Black, S.E., Brayne, C., B r e t e l e r ,M .",Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1159/00032049120881397 .,Non-OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
"Neuroimage 53 (1), 16 –25.http://dx.doi.org/10.1016/ j.neuroimage.2010.05.06820595067 .",OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.06.,OADS,/arxiv_data1/oa_pdf/9e/34/main.PMC4338206.pdf
http://dx.doi.org/10.1016/j.nicl.2015.01.005 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
Data processing work ﬂows were designed and implemented at the Laboratory of Neuro- imaging (LONI) Pipeline ( http://pipeline.loni.usc.edu ).,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
"Tractography was performed via the Fiber As- signment by Continuous Tracking (FACT) algorithm ( Mori et al., 1999 ) using TrackVis ( http://trackvis.org )(Irimia et al., 2012 ).",OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
"3, 32. http://dx.doi.org/10.3389/neuro.09.032.200919893761 .",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
"1 (3), 31. http://dx.doi.org/10.1186/ gm3119341502 .",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/j.brainres.2010.12.00821146506 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.2174/13892021179567789522043165 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1111/nmo.1212523566308 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/S2213-8587(14)70134- 225066177 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/j.autneu.2010.09.00520926356 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1006/ nimg.1998.03959931268 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/j.nut.2009.09.02020022465 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.06.01020547229 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1038/ nrendo.2013.5723529041 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1377/hlthaff.28.5.w82219635784 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/S0896- 6273(02)00569-X11832223 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1146/annurev-immunol-031210- 10132221219177 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
"http://dx.doi.org/10.1159/ 00029774220299802 .Gunstad, J., Paul, R.H., Cohen, R.A., Tate, D.F., Gordon, E., 2006.",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1007/BF0332774716801734 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
"Psychiatry 48 (1), 57 –61.http://dx.doi.org/10.1016/j.comppsych.",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/ 10.1016/j.appet.2007.07.00817761359 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.01.,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/j.neulet.2014.07.02425058432 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/j.neuron.2011.02.01621338878 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1053/j.gastro.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1002/hbm.2126821520345 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
"BMC Bioinfor- matics 12, 253. http://dx.doi.org/10.1186/1471-2105-12-25321693065 .",OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
"BMC Bioinformatics 10, 34. http://dx.doi.org/10.1186/1471-2105-10-3419171069 .",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.3310/hta1502021247515 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1007/ s00429-010-0262-020512370 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1002/1531-8249(199902)45:2 b265::AID-ANA21 N3.0.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/j.neuroimage.2006.,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1038/ijo.2014.5724727578 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1002/hbm.2087019662657 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.5587-06.200717329432 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
Int J Obes (Lond) http://dx.doi.org/10.1038/ijo.2014.12125027223 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1523/JNEUROSCI.6604-10.201121430137 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1080/ 8756564100368955620446131 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
"http://dx.doi.org/10.1007/s11695- 012-0608-122290621 .Volkow, N.D., Frascella, J., Friedman, J., Saper, C.B., Baldo, B., Rolls, E.T., Mennella, J.A., Dallman, M.F., Wang, G.J., LeFur, G., 2004.",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
"15 (1), 37 –46.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1098/rstb.2008.010718640912 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1007/s00125-010- 1857-y20668831 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1002/oby.2080124891029 .,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1016/S0165- 0173(02)00248-512505650 .,OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
http://dx.doi.org/10.1111/j.1600-0447.1983.,Non-OADS,/arxiv_data1/oa_pdf/c1/ee/main.PMC4338207.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d1/64/dddt-9-901.PMC4338255.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 901–909Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  901Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7515 2Upregulation of PD-l1 and aPe1 is associated  with tumorigenesis and poor prognosis of  gastric cancer Yi Qing1,* Qing li1,* Tao ren1 Wei Xia1 Yu Peng1 gao-lei liu2 hao luo1 Yu-Xin Yang1 Xiao-Yan Dai1 shu-Feng Zhou3 Dong Wang1 1cancer center, 2Urological surgery,  Daping hospital and research institute  of surgery, Third Military Medical  University, chongqing, People’s  republic of china; 3Department of  Pharmaceutical sciences, college of  Pharmacy, University of south Florida,  Tampa, Fl, Usa *These authors contributed equally  to this workIntroduction:  Gastric cancer is a fatal malignancy with a rising incidence rate.",Non-OADS,/arxiv_data1/oa_pdf/d1/64/dddt-9-901.PMC4338255.pdf
"Immunotherapy has shown bright promise in the  treatment of gastric cancer.4,5 Unfortunately, it was reported that gastric cancer cells  can escape immune surveillance by a variety of mechanisms which prevent the immune  system from producing effective antitumor immune responses.6 Moreover, the body’s correspondence: Dong Wang cancer center, Daping hospital  and research institute of surgery,  Third Military Medical University,  no 10 changjiang Zhi rd, Yu  Zhong District, chongqing 400042,  People’s republic of china Tel +86 23 6875 7151 Fax +86 23 6889 4062 email dongwang64@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Qing et al Running head recto: PD-L1 and APE1 in tumorigenesis and gastric cancer prognosis DOI: http://dx.doi.org/10.2147/DDDT.S75152",Non-OADS,/arxiv_data1/oa_pdf/d1/64/dddt-9-901.PMC4338255.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d1/64/dddt-9-901.PMC4338255.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d1/64/dddt-9-901.PMC4338255.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/29/dddt-9-879.PMC4338256.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 879–886Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  879Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6994 6Tazarotene as alternative topical treatment  for onychomycosis elena campione1 evelin Jasmine Paternò2 gaetana costanza2,3 laura Diluvio1 isabella carboni1 Daniele Marino4 cartesio Favalli4 sergio chimenti1 luca Bianchi1 augusto Orlandi2,3 1Department of Dermatology,   2Department of Biomedicine  and Prevention, 3Department  of anatomic Pathology, Policlinic Tor  Vergata, 4Department of Microbiology,   University of rome T or Vergata, rome,   italyBackground:  Distal and lateral onychomycoses are the most frequent forms of onychomycosis,  causing subungual hyperkeratosis that usually limits local penetration of antimycotic drugs.",Non-OADS,/arxiv_data1/oa_pdf/dd/29/dddt-9-879.PMC4338256.pdf
"Aging and reduced  peripheral circulation are among the major risk factors for onychomycosis; diabetes  weakens the immune function, favoring slow nail growth, thickening, and susceptibility to  infections and nail injury.4–7 Onychomycosis sometimes is associated with nail psoriasis,  correspondence: elena campione Department of Dermatology, University  of rome Tor Vergata, Viale Oxford 81,  rome 00133, italy Tel +39 06 2090 0252 Fax +39 06 2090 2742 email campioneelena@hotmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Campione et al Running head recto: Tazarotene therapy of onychomycosis DOI: http://dx.doi.org/10.2147/DDDT.S69946",Non-OADS,/arxiv_data1/oa_pdf/dd/29/dddt-9-879.PMC4338256.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/dd/29/dddt-9-879.PMC4338256.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/29/dddt-9-879.PMC4338256.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/d3/dddt-9-867.PMC4338257.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 867–877Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  867Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7276 5anesthetic drug midazolam inhibits cardiac  human ether-à-go-go-related gene channels:  mode of action nadine Vonderlin1 Fathima Fischer1 edgar Zitron1,2 claudia seyler1 Daniel scherer1 Dierk Thomas1,2 hugo a Katus1,2 eberhard P scholz1 1Department of internal Medicine iii,   University hospital heidelberg,   2german centre for cardiovascular  research, Partner site heidelberg/ Mannheim, heidelberg, germanyAbstract:  Midazolam is a short-acting benzodiazepine that is in wide clinical use as an  anxiolytic, sedative, hypnotic, and anticonvulsant.",Non-OADS,/arxiv_data1/oa_pdf/ae/d3/dddt-9-867.PMC4338257.pdf
"Drowsiness starts  approximately 15 minutes after oral administration and 3 minutes after intravenous  application.4 When compared with other benzodiazepines, midazolam exhibits the  shortest recovery time and a high metabolic clearance.5 Midazolam is known to be  relatively safe in clinical practice, and the effects on cardiac repolarization have been correspondence: eberhard P scholz Department of internal Medicine iii  (cardiology), University hospital  heidelberg, im neuenheimer Feld 410,  69120 heidelberg, germany Tel +49 622 156 8855 Fax +49 622 1563 3497 email eberhard.scholz@med.uni- heidelberg.d e Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Vonderlin et al Running head recto: Inhibition of cardiac hERG channel by midazolam DOI: http://dx.doi.org/10.2147/DDDT.S72765",Non-OADS,/arxiv_data1/oa_pdf/ae/d3/dddt-9-867.PMC4338257.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ae/d3/dddt-9-867.PMC4338257.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/d3/dddt-9-867.PMC4338257.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/7e/dddt-9-887.PMC4338258.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 887–900Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  887Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7801 5Treatment with a herbal formula B401 enhances  neuroprotection and angiogenesis in the r6/2  mouse model of huntington’s disease sheue-er Wang1 ching-lung lin1 chih-hsiang hsu1 shuenn-Jyi sheu2 chiang-Ting chien1 chung-hsin Wu1 1Department of life science,   national Taiwan normal University,   2Brion research institute of Taiwan,   Taipei,  TaiwanAbstract:  Huntington’s disease (HD) is a neurodegenerative disease characterized by motor  dysfunction and early death.",Non-OADS,/arxiv_data1/oa_pdf/dd/7e/dddt-9-887.PMC4338258.pdf
"The Chinese herbal formula B401 may serve as a potential therapeutic strategy  for HD brain atrophy.correspondence: chung-hsin Wu Department of life science, national  Taiwan normal University, 88, Ting-chou  road, section 4, Taipei 11677, Taiwan Tel +886 2 7734 6363 Fax +886 2 2931 2904 email megawu@ntnu.edu.t w Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wang et al Running head recto: Neuroprotective effects of B401 in HD mice DOI: http://dx.doi.org/10.2147/DDDT.S78015 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/dd/7e/dddt-9-887.PMC4338258.pdf
Or use: http://dvpr.es/1ET6mq YVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/dd/7e/dddt-9-887.PMC4338258.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/dd/7e/dddt-9-887.PMC4338258.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/7e/dddt-9-887.PMC4338258.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/e8/dddt-9-841.PMC4338259.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 841–866Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  841Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7466 9estimation of the binding modes with important  human cytochrome P450 enzymes, drug  interaction potential, pharmacokinetics,  and hepatotoxicity of ginger components  using molecular docking, computational,  and pharmacokinetic modeling studies Jia-Xuan Qiu1,2 Zhi-Wei Zhou3 Zhi-Xu he4 Xueji Zhang5 shu-Feng Zhou3 shengrong Zhu1 1Department of stomatology, Tongji  hospital, Tongji Medical college, huazhong  University of science and T echnology,   Wuhan, hubei, People’s republic of china;   2Department of Oral and Maxillofacial  surgery, The First affiliated hospital of  nanchang University, nanchang, Jiangxi,   People’s republic of china; 3Department  of Pharmaceutical sciences, college of  Pharmacy, University of south Florida,   Tampa, Fl, Usa; 4guizhou Provincial Key  laboratory for regenerative Medicine,   stem cell and Tissue engineering research  center and sino-Us Joint laboratory  for Medical sciences, guiyang Medical  University, guiyang, guizhou, People’s  republic of china; 5research center  for Bioengineering and sensing T echnology,   University of science and Technology  Beijing, Beijing, People’s republic of chinaAbstract:  Ginger is one of the most commonly used herbal medicines for the treatment of  numerous ailments and improvement of body functions.",Non-OADS,/arxiv_data1/oa_pdf/52/e8/dddt-9-841.PMC4338259.pdf
"Keywords:  CYP, drug metabolism, ginger, drug interaction, dockingcorrespondence: shengrong Zhu Department of stomatology, Tongji hospital,  Tongji Medical college, huazhong University  of science and Technology, Wuhan 430030,  hubei, People’s republic of china Tel +86 27 8366 3225  Fax +86 27 8366 2688 email zhushengrong@163.co m  shu-Feng Zhou Department of Pharmaceutical sciences,  college of Pharmacy, University of south  Florida, 12901 Bruce B Downs Boulevard,  Tampa, Fl 33612, Usa Tel +1 813 974 6276  Fax +1 813 905 9885 email szhou@health.usf.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Qiu et al Running head recto: Estimation of the binding modes and ADMET of ginger components DOI: http://dx.doi.org/10.2147/DDDT.S74669",Non-OADS,/arxiv_data1/oa_pdf/52/e8/dddt-9-841.PMC4338259.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/52/e8/dddt-9-841.PMC4338259.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/e8/dddt-9-841.PMC4338259.pdf
"1: 1-8, February, 2015http://dx.doi.org/10.4110/in.2015.15.1.1 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 1Received on November 25, 2014.",Non-OADS,/arxiv_data1/oa_pdf/0a/96/in-15-1.PMC4338263.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/96/in-15-1.PMC4338263.pdf
"1: 16-26, February, 2015http://dx.doi.org/10.4110/in.2015.15.1.16 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 16Received on December 6, 2014.",Non-OADS,/arxiv_data1/oa_pdf/7d/4c/in-15-16.PMC4338264.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7d/4c/in-15-16.PMC4338264.pdf
"1: 27-36, February, 2015http://dx.doi.org/10.4110/in.2015.15.1.27 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 27Received on November 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/14/fb/in-15-27.PMC4338265.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/fb/in-15-27.PMC4338265.pdf
"1: 37-43, February, 2015http://dx.doi.org/10.4110/in.2015.15.1.37 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 37Received on November 22, 2014.",Non-OADS,/arxiv_data1/oa_pdf/f5/28/in-15-37.PMC4338266.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f5/28/in-15-37.PMC4338266.pdf
"1: 44-49, February, 2015http://dx.doi.org/10.4110/in.2015.15.1.44 pISSN 1598-2629    eISSN 2092-6685ORIGINAL ARTICLE 44Received on December 7, 2014.",Non-OADS,/arxiv_data1/oa_pdf/e0/c6/in-15-44.PMC4338267.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/c6/in-15-44.PMC4338267.pdf
"1: 9-15, February, 2015http://dx.doi.org/10.4110/in.2015.15.1.9 pISSN 1598-2629    eISSN 2092-6685REVIEW ARTICLE 9Received on January 16, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fe/cb/in-15-9.PMC4338268.pdf
"CC This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0) wh ich permits unrestricted non-commercial use, distribu- tion, and reproduction in any medium, provid ed the original work  is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/cb/in-15-9.PMC4338268.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/ab/main.PMC4338310.pdf
"Received December 16, 2014 /C15Revision received December 24, 2014 /C15Accepted January 3, 2015 /C15Available online 9 January 2015 http://dx.doi.org/10.1016/j.molmet.2015.01.001 Brief communication 246MOLECULAR METABOLISM 4 (2015) 246 e252/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/13/ab/main.PMC4338310.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/ab/main.PMC4338310.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/ab/main.PMC4338310.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/ab/main.PMC4338310.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/ab/main.PMC4338310.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/ab/main.PMC4338310.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/ab/main.PMC4338310.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/ab/main.PMC4338310.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/74/main.PMC4338311.pdf
"Received December 1, 2014 /C15Revision received December 10, 2014 /C15Accepted December 12, 2014 /C15Available online 19 December 2014 http://dx.doi.org/10.1016/j.molmet.2014.12.007 Brief communication 222MOLECULAR METABOLISM 4 (2015) 222 e226/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/40/74/main.PMC4338311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/74/main.PMC4338311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/74/main.PMC4338311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/74/main.PMC4338311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/74/main.PMC4338311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/74/main.PMC4338311.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
"Received December 16, 2014 /C15Revision received December 22, 2014 /C15Accepted December 23, 2014 /C15Available online 2 January 2015 http://dx.doi.org/10.1016/j.molmet.2014.12.011 Original article 186MOLECULAR METABOLISM 4 (2015) 186 e198/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/61/f6/main.PMC4338312.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
"Received November 24, 2014 /C15Revision received December 18, 2014 /C15Accepted December 23, 2014 /C15Available online 2 January 2015 http://dx.doi.org/10.1016/j.molmet.2014.12.012 Original article MOLECULAR METABOLISM 4 (2015) 151 e163/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a1/2e/main.PMC4338313.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
"Received November 26, 2014 /C15Revision received December 12, 2014 /C15Accepted December 13, 2014 /C15Available online 19 December 2014 http://dx.doi.org/10.1016/j.molmet.2014.12.006 Brief communication MOLECULAR METABOLISM 4 (2015) 227 e236/C2112014 The Authors.",OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/de/50/main.PMC4338314.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
"Abbreviations: ARH, arcuate nucleus of the hypothalamus; DIO, diet-induced obesity; DMH, dorsomedial nucleus of the hypothalamus; EGWG, excessive gestational we ight gain; GDM, gestational diabetes mellitus; GTT, glucose tolerance test; IR, insulin receptor; ITT, insulin tolerance test; LepR, leptin receptor; P KC, protein kinase C; GH-V, placental growth hormone; pSTAT3, phosphorylation of the signal transducer and activator of transcription 3; pSTAT3-ir, pSTAT3-immunoreactive; RP, retroperitoneal; SOCS3, suppressor of cytokine signaling-3; STZ, streptozotocin; VMH, ventromedial nucleus of the hypothalamus Received November 24, 2014 /C15Revision received December 8, 2014 /C15Accepted December 12, 2014 /C15Available online 20 December 2014 http://dx.doi.org/10.1016/j.molmet.2014.12.005 Brief communication MOLECULAR METABOLISM 4 (2015) 237 e245/C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f8/7e/main.PMC4338315.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
"Received November 27, 2014 /C15Revision received December 15, 2014 /C15Accepted December 18, 2014 /C15Available online 16 January 2015 http://dx.doi.org/10.1016/j.molmet.2014.12.010 Original article 164MOLECULAR METABOLISM 4 (2015) 164 e174/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/91/main.PMC4338316.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
"Abbreviations: VLDL, very low-density lipoprotein; TG, triglyceride; CNS, central nervous system; NPY, neuropeptide Y; POMC, proopiomelanocortin; icv, intra- cerebroventricular; SNS, sympathetic nervous system; FFA(s), free fatty acid(s); ApoB, apolipoprotein B; ER, endoplasmic reticulum; PL, phospho lipid; ARF-1, ADP-ribo- sylation factor-1; PLD, phospholipase D; PA, phosphatidic acid; AGPAT, 1-acyl-glycerol-3-phosphate acyltransferase; PAP-1, phosphatidic acid phosphatase-1; DAG, diacylglycerol; DGAT, diacylglycerol acyltransferase; SCD-1, stearoyl-CoA desaturase-1; ZF, Zucker fatty; ad-lib , ad-libitum; PF, pair-fed; Veh, vehicle; Sham, sham- denervation; Sx, sympathetic denervation; NE, norepinephrine; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; HDAC-1, histone deacetylase- 1; RT-PCR, real-time PCR; RPL13A, ribosomal protein L13a; Nuc, nuclear; Cyto, cytoplasmic Received December 15, 2014 /C15Revision received December 29, 2014 /C15Accepted January 9, 2015 /C15Available online 16 January 2015 http://dx.doi.org/10.1016/j.molmet.2015.01.004 Original article 210MOLECULAR METABOLISM 4 (2015) 210 e221 Published by Elsevier GmbH.",Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/a6/main.PMC4338317.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
"Received December 19, 2014 /C15Revision received December 31, 2014 /C15Accepted January 8, 2015 /C15Available online 21 January 2015 http://dx.doi.org/10.1016/j.molmet.2015.01.002 Original article MOLECULAR METABOLISM 4 (2015) 175 e185/C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
SUPPLEMENTARY DATA Supplementary data related to this article can be found at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/19/dd/main.PMC4338319.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.045138.114.,OADS,/arxiv_data1/oa_pdf/7c/42/347.PMC4338332.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Internation-al), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/7c/42/347.PMC4338332.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048843.114.© 2015 Iannone et al.,Non-OADS,/arxiv_data1/oa_pdf/07/94/360.PMC4338333.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/07/94/360.PMC4338333.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/07/94/360.PMC4338333.pdf
Combined strength of 5′ and 3′splice sites was measured by Analyze Splice Tool (http://ibis.tau.ac.il/ssat/SpliceSiteFrame.htm).,OADS,/arxiv_data1/oa_pdf/07/94/360.PMC4338333.pdf
"Exonquantifications (summarized per-genes) were used for expressionlevel determination, either as raw read counts or as reads per kilo-base per million mapped reads (RPKM) using Flux Capacitor(http://liorpachter.wordpress.com/tag/flux-capacitor/).",OADS,/arxiv_data1/oa_pdf/07/94/360.PMC4338333.pdf
"Splice site scoring and GC content percent All exons expressed in T47D at T0 were extracted from MISO anno-tation, as described in Clustering and Aggregation of NucleosomeSignal, and scored using “Analyzer-Splice-Tool ”(http://ibis.tau.ac.",OADS,/arxiv_data1/oa_pdf/07/94/360.PMC4338333.pdf
"2013) (http://cisbp-rna.ccbr.utoronto.ca/index.php),which has an identity of 0.814 with the human RBD.",OADS,/arxiv_data1/oa_pdf/07/94/360.PMC4338333.pdf
"Using SFmap(http://sfmap.technion.ac.il/index.html), enrichment of the predict-ed hnRNP AB motif was assessed in R5020-regulated exons and asubset of 247 random, not R5020-regulated alternative internal ex-ons in the following regions: 100 bp starting from the 3 ′ss, 450 bp upstream of the 3′ss, and downstream from the 5′ss, divided in bins of 150 bp.",Non-OADS,/arxiv_data1/oa_pdf/07/94/360.PMC4338333.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.049098.114.© 2015 Chak et al.,OADS,/arxiv_data1/oa_pdf/c8/f2/375.PMC4338334.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/c8/f2/375.PMC4338334.pdf
"Processing was carried out with Fastx-toolkit v0.0.13.2 (http://hannonlab.cshl.edu/fastx_toolkit), BEDOPSv2.20 (Neph et al.",OADS,/arxiv_data1/oa_pdf/c8/f2/375.PMC4338334.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048744.114.© 2015 Huang et al.,OADS,/arxiv_data1/oa_pdf/75/81/385.PMC4338335.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/75/81/385.PMC4338335.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/75/81/385.PMC4338335.pdf
"Bioinformatic analysis Computer-based programs including Targetscan (http://www.targetscan.org/), Pictar (http://pictar.mdc-berlin.de/), Microinspec-tor (http://bioinfo.uni-plovdiv.bg/microinspector/), RNAhybrid(http://www.bibiserv.techfak.uni-bielefeld.de/), and DIANA (http://diana.cslab.ece.ntua.gr) were used to predict potential targets for miR-130a.",OADS,/arxiv_data1/oa_pdf/75/81/385.PMC4338335.pdf
"ACKNOWLEDGMENTS We thank the technical support from the Affymetrix Gene Expres-sion Service Lab (http://ipmb.sinica.edu.tw/affy/), Academia Sinica,Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/75/81/385.PMC4338335.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048942.114.© 2015 Jacewicz et al.,OADS,/arxiv_data1/oa_pdf/e8/e0/401.PMC4338336.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e8/e0/401.PMC4338336.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/e8/e0/401.PMC4338336.pdf
The stringent requirements of Msl5 for U 4 and A6are consistent with the compre- hensive database of spliced yeast RNAs compiled by the Ares laboratory (http://intron.ucsc.edu/yeast4.1/) in which there are no naturally occurring yeast in- trons that have a nucleobase other than Uat position 4 and A at position 6.,Non-OADS,/arxiv_data1/oa_pdf/e8/e0/401.PMC4338336.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.047563.114.© 2015 Weis et al.,OADS,/arxiv_data1/oa_pdf/27/95/415.PMC4338337.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/27/95/415.PMC4338337.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048520.114.© 2015 Wang et al.,OADS,/arxiv_data1/oa_pdf/2b/50/426.PMC4338338.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/2b/50/426.PMC4338338.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/2b/50/426.PMC4338338.pdf
Bioinformatics Analysis of sequence conservation in the NXF1 gene intron 10 of different mammalian species was facilitated using genomicevolutionary rate profiling (GERP) (http://mendel.stanford.edu/SidowLab/downloads/gerp/index.html) and the Ensembl genomebrowser (http://www.ensembl.org/index.html).,OADS,/arxiv_data1/oa_pdf/2b/50/426.PMC4338338.pdf
CTE sequenceBLAST searches against other NXF1 genes were performed using National Center for Biotechnology BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and with the Ensembl genome browser (http://www.ensembl.org/Multi/Tools/Blast).,OADS,/arxiv_data1/oa_pdf/2b/50/426.PMC4338338.pdf
RNA secondary structureanalyses were performed using Mfold (http://mfold.rna.albany.edu/?q=mfold/DNA-Folding-Form).,OADS,/arxiv_data1/oa_pdf/2b/50/426.PMC4338338.pdf
(EMBOSS: TheEuropean Molecular Biology Open Software Suite [2000]) availableat http://emboss.sourceforge.net/interfaces/#jemboss and manip-ulated using GeneDoc (http://www.nrbsc.org/gfx/genedoc/ebinet.htm) (Rice et al.,OADS,/arxiv_data1/oa_pdf/2b/50/426.PMC4338338.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.047258.114.© 2015 Becerra et al.,OADS,/arxiv_data1/oa_pdf/79/d4/438.PMC4338339.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/79/d4/438.PMC4338339.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/79/d4/438.PMC4338339.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048033.114.,OADS,/arxiv_data1/oa_pdf/c1/2e/458.PMC4338340.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD 458 RNA 21:458 –469; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/c1/2e/458.PMC4338340.pdf
"For rounds 2, 3, 6, and 9, the 20 clones characterized in Bwere sequenced and, after sequence alignment, a logo representation generated using WebLogo3.3 (http://weblogo.threeplusone.com).Droplet-based microfluidics for evolving RNA www.rnajournal.org 465",OADS,/arxiv_data1/oa_pdf/c1/2e/458.PMC4338340.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.047662.114.© 2015 Wang et al.,OADS,/arxiv_data1/oa_pdf/58/6c/145.PMC4338343.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/58/6c/145.PMC4338343.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS RNA 21:145 –163; Published by Cold Spring Harbor Laboratory Press for the RNA Society 145",Non-OADS,/arxiv_data1/oa_pdf/58/6c/145.PMC4338343.pdf
The predicted branch point se-quences for both Arabidopsis thaliana and Oryza sativa (brach_ download.gz) were downloaded from Database of Plant SpliceSites and Splicing Signals (http://lemur.amu.edu.pl/share/ERISdb/home.html) (Szcze ´sniak et al.,OADS,/arxiv_data1/oa_pdf/58/6c/145.PMC4338343.pdf
Gene ontology analyses The brachy_v1.0 GO terms library was downloaded from the Mu-nich information center for protein sequence (MIPS) (http://mips.helmholtz-muenchen.de/) (International Brachypodium Initiative2010).,OADS,/arxiv_data1/oa_pdf/58/6c/145.PMC4338343.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.046060.114.© 2015 Campbell et al.,OADS,/arxiv_data1/oa_pdf/e5/fa/164.PMC4338344.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e5/fa/164.PMC4338344.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS 164 RNA 21:164 –171; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/e5/fa/164.PMC4338344.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048272.114.© 2015 Wang and Wang This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http:// rnajournal.cshlp.org/site/misc/terms.xhtml).,OADS,/arxiv_data1/oa_pdf/2a/88/172.PMC4338345.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 172 RNA 21:172 –179; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/2a/88/172.PMC4338345.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.047910.114.,OADS,/arxiv_data1/oa_pdf/66/53/180.PMC4338346.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Internation-al), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 180 RNA 21:180 –187; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/66/53/180.PMC4338346.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048173.114.© 2015 Han et al.,OADS,/arxiv_data1/oa_pdf/15/d4/188.PMC4338347.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/15/d4/188.PMC4338347.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048199.114.,OADS,/arxiv_data1/oa_pdf/a0/26/202.PMC4338348.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/a0/26/202.PMC4338348.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048009.114.© 2015 Arias et al.,OADS,/arxiv_data1/oa_pdf/b3/59/213.PMC4338349.pdf
"After 12 months, it is avail- able under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/b3/59/213.PMC4338349.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.045799.114.© 2015 Ikeda et al.,OADS,/arxiv_data1/oa_pdf/cb/82/230.PMC4338350.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/cb/82/230.PMC4338350.pdf
"In step 4, the sequence reads that mapped to the T. cancriformis cDNAs (3981 expressed sequence tags and 579 genes) from the NationalCenter for Biotechnology Information (NCBI; http://www.ncbi.nlm.nih.gov, October 2013), or to the internal transcribed spacer(ITS) region (AB930494) between 18S rRNA and 28S rRNA wereremoved.",OADS,/arxiv_data1/oa_pdf/cb/82/230.PMC4338350.pdf
elegans genomes were downloaded from the University of California at Santa Cruz(UCSC) genome browser (http://genome.ucsc.edu/) and theDaphnia pulex genome was obtained from Joint Genome Institute (JGI) (http://www.jgi.doe.gov/).,OADS,/arxiv_data1/oa_pdf/cb/82/230.PMC4338350.pdf
"2013), JGI, or UniProt (http://www.uniprot.org,October 2013), and multiple alignments of these amino acid se-quences were generated with MUSCLE.",OADS,/arxiv_data1/oa_pdf/cb/82/230.PMC4338350.pdf
"DATA DEPOSITION The nucleotide sequences of the T. cancriformis small RNAs and ge- nomic DNA have been deposited in the DNA Data Bank of Japan(DDBJ) (http://www.ddbj.nig.ac.jp/index-e.html) under accessionnumbers PRJDB1672 and PRJDB1662, respectively.",OADS,/arxiv_data1/oa_pdf/cb/82/230.PMC4338350.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048389.114.© 2015 Rao and Jackman This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http:// rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/28/65/243.PMC4338351.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/28/65/243.PMC4338351.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048959.114.© 2015 Niederer and Zappulla This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/4a/1d/254.PMC4338352.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/4a/1d/254.PMC4338352.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048090.114.© 2015 Tiedje et al.,OADS,/arxiv_data1/oa_pdf/ec/5f/262.PMC4338353.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/ec/5f/262.PMC4338353.pdf
"RBM39-fwd (GTGCTGTGGCAGAATTCTCTT) andRBM39-rev (TTGTGTTGCAAGTGGCTGA) primers to detectthe RBM39 coding gene were designed with the help of thePrimer3 online tool (Primer3, http://www-genome.wi.mit.edu/genome_software/other/primer3.html).",OADS,/arxiv_data1/oa_pdf/ec/5f/262.PMC4338353.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.047787.114.© 2015 Schweidenback et al.,OADS,/arxiv_data1/oa_pdf/a1/ab/279.PMC4338354.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/a1/ab/279.PMC4338354.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommer-cial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/a1/ab/279.PMC4338354.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.047159.114.,OADS,/arxiv_data1/oa_pdf/ac/13/296.PMC4338355.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Internation-al), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD 296 RNA 21:296 –305; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/ac/13/296.PMC4338355.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/92/1d/main.PMC4338369.pdf
The amino acid sequence of NADH oxidase exhibits http://dx.doi.org/10.1016/j.fob.2015.01.005 2211-5463/ /C2112015 The Authors.,OADS,/arxiv_data1/oa_pdf/92/1d/main.PMC4338369.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: Nox, NADH oxidase; AhpC (Prx), peroxiredoxin; AS, ammonium sulfate; SPR, surface plasmon resonance; DLS, dynamic light scattering; AUC,analytical ultracentrifugation; SAXS, small-angle X-ray scattering ⇑Corresponding author at: The Department of Bioscience, Tokyo University of Agriculture, 1-1-1 Sakuragaoka, Setagayaku, Tokyo 156-8502, Japan.",Non-OADS,/arxiv_data1/oa_pdf/92/1d/main.PMC4338369.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.01.005 .",OADS,/arxiv_data1/oa_pdf/92/1d/main.PMC4338369.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/95/2d/main.PMC4338370.pdf
http://dx.doi.org/10.1016/j.fob.2015.01.008 2211-5463/ /C2112015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/95/2d/main.PMC4338370.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: SPH, serine protease homolog; JNK, Jun N-terminal Kinase; UAS, Upstream Activation Sequence; DPP, Decapentaplegic ⇑Corresponding author at: Department of Biology and Biotechnology Center, Western Kentucky University, 1906 College Heights Boulevard, TCCW 351, BowlingGreen, KY 42101, USA.",Non-OADS,/arxiv_data1/oa_pdf/95/2d/main.PMC4338370.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.01.008 .",OADS,/arxiv_data1/oa_pdf/95/2d/main.PMC4338370.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/40/ee/main.PMC4338371.pdf
"It was also shown that the enzyme has high afﬁnity for the reaction product 8-oxo-dGMP with a KDof 52 nM that is 34,600 fold lower than that http://dx.doi.org/10.1016/j.fob.2015.01.006 2211-5463/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/40/ee/main.PMC4338371.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: 8-oxoG, 8-oxo-Guanine; Nudix, nucleoside diphosphates linked to some other moiety X; RMSD, root mean square deviation; MTH1, MutThomologue 1 from human; A:T to C:G, adenine:thymine to cytosine:guanine;NMR, nuclear magnetic resonance; DSC, differential scanning calorimetry; ROS,reactive oxygen species; E a, activation energy ⇑Corresponding authors.",Non-OADS,/arxiv_data1/oa_pdf/40/ee/main.PMC4338371.pdf
"Ion pair formation was investigated by the WHAT IF Web Inter- face ( http://swift.cmbi.ru.nl/servers/html/index.html )[30] with interatomic distances <6 Å or <4 Å between the side chains of Asp or Glu to Arg, Lys or His residues.",OADS,/arxiv_data1/oa_pdf/40/ee/main.PMC4338371.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0a/34/main.PMC4338372.pdf
"Among ELMO upward modulators, RhoG, in its GTP-bound form, interacts with http://dx.doi.org/10.1016/j.fob.2015.01.009 2211-5463/ /C2112015 The Authors.",OADS,/arxiv_data1/oa_pdf/0a/34/main.PMC4338372.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: ELMO, EnguLfment and cell MOtility protein family; DOCK, Downstream Of CrK protein family; GEF, Guanine nucleotide Exchange Factor; ERM,Ezrin–Radixin–Moesin protein family; TAMs, Tyro3, Axl and Mer receptor tyrosinekinase family; Hck, Hematopoietic cell kinase; SH3, Src Homology 3 domain; RBD, Rho-Binding Domain; EID, ELMO Inhibitory Domain; PH, Pleckstrin Homology domain; EAD, ELMO Autoregulatory Domain; PxP, Polyproline motif; GST, Glu-tathione S-Transferase; GSH, Glutathione (reduced); TEV, Tobacco Etch Virus; FRET,Förster (Fluorescence) resonance energy transfer ⇑Corresponding author at: Institut de Biologie Structurale UMR 5075, 71 avenue des Martyrs, CS10090, F-38044 Grenoble Cedex 9, France.",Non-OADS,/arxiv_data1/oa_pdf/0a/34/main.PMC4338372.pdf
URL: http://www.ibs.fr (K. Jean-Philippe).FEBS Open Bio 5 (2015) 99–106 journal homepage: www.elsevier .com/locate/febsopenbio,Non-OADS,/arxiv_data1/oa_pdf/0a/34/main.PMC4338372.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2015.01.009 .",OADS,/arxiv_data1/oa_pdf/0a/34/main.PMC4338372.pdf
"Methods   Search Strategy   The PubMed database (http://www.ncbi.nlm.nih.gov/pubmed/) was searched for obser- vational studies investigating the relationship between dietary  or blood ARA levels and  cerebral ischemia risk that were published up to June 24, 2014.",OADS,/arxiv_data1/oa_pdf/99/b8/cee-0004-0198.PMC4338408.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ Supplementary Information accompanies this paper on the Nutrition & Diabetes website (http://www.nature.com/nutd)Adipokine expression in fatty liver disease MGM Wolfs et al 7 Nutrition & Diabetes (2015) 1 –7",Non-OADS,/arxiv_data1/oa_pdf/d0/c9/nutd201443a.PMC4338415.pdf
2013 https://www.gov.uk/government/policies/reducing-obesity-and-improving-diet (accessed 24 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/ab/16/nutd201447a.PMC4338416.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Nutrition & Diabetes website (http://www.nature.com/nutd)Early-life exposures/adolescent body composition SD Leary et al 7 Nutrition & Diabetes (2015), 1 –7",Non-OADS,/arxiv_data1/oa_pdf/ab/16/nutd201447a.PMC4338416.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8564 | DOI: 10.1038/srep08564 9",Non-OADS,/arxiv_data1/oa_pdf/95/02/srep08564.PMC4338434.pdf
(Cell Mol Gastroenterol Hepatol 2015;1:55 –74; http://dx.doi.org/ 10.1016/j.jcmgh.2014.08.001 ) Keywords: Antimicrobial Peptide; Collagen; In ﬂammatory Bowel Disease.,Non-OADS,/arxiv_data1/oa_pdf/c4/23/main.PMC4338438.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c4/23/main.PMC4338438.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2014.08.001,OADS,/arxiv_data1/oa_pdf/c4/23/main.PMC4338438.pdf
Available from: http://www.rabies.or.in/wp-content/uploads/2009/11/ whosurvey.pdf  [Last accessed on 2009 Nov 14].,Non-OADS,/arxiv_data1/oa_pdf/18/50/JGID-7-1.PMC4338442.pdf
Available from: http://www.who.int/rabies/PEP_prophylaxis_guidelines_June10.pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/50/JGID-7-1.PMC4338442.pdf
Available  from: http://www.fao.org/ag/agp/AGPC/doc/Counprof/zambia/ zambia.htm#_Toc131995467.,Non-OADS,/arxiv_data1/oa_pdf/ba/07/JGID-7-11.PMC4338443.pdf
Available from: http://1worldmap.com/ Zambia/Western-Province.,Non-OADS,/arxiv_data1/oa_pdf/ba/07/JGID-7-11.PMC4338443.pdf
Available from: http://1worldmap.com/ Zambia/North-Western-Province.,Non-OADS,/arxiv_data1/oa_pdf/ba/07/JGID-7-11.PMC4338443.pdf
Available from: http://www.zambiatourism.com/about- zambia/climate.,Non-OADS,/arxiv_data1/oa_pdf/ba/07/JGID-7-11.PMC4338443.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/5e/51/JGID-7-18.PMC4338444.pdf
Available from: http://www.jhpdc.unc.edu/ [Last accessed on 2005].,Non-OADS,/arxiv_data1/oa_pdf/dd/7d/JGID-7-23.PMC4338445.pdf
Available from: http://www.dx.doi.org/10.1111/j.1740-8709.2007.00124.x [Last accessed on 2014 Nov 10].,Non-OADS,/arxiv_data1/oa_pdf/dd/7d/JGID-7-23.PMC4338445.pdf
Available from: http://www.nfhsindia.org?nfhs3- national-report.html.,Non-OADS,/arxiv_data1/oa_pdf/dd/7d/JGID-7-23.PMC4338445.pdf
Available from: http://www.rrh.org.au.,Non-OADS,/arxiv_data1/oa_pdf/dd/7d/JGID-7-23.PMC4338445.pdf
2004. http://rabies.org.in/rabiesjournal/rabies-06/SpecialArticle1.htm.,Non-OADS,/arxiv_data1/oa_pdf/a1/15/JGID-7-30.PMC4338447.pdf
Geneva: World Health Organization; 2005. http://apps.who.int/iris/bitstream/10665/85346/1/9789241209823_eng.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a1/15/JGID-7-30.PMC4338447.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/97/62/JGID-7-35.PMC4338449.pdf
Available from:  http://www.cdc.gov/tb/statistics/reports/2012/pdf/report2012.pdf.,OADS,/arxiv_data1/oa_pdf/0e/d2/JGID-7-44.PMC4338453.pdf
Available from:  http://www.cdc.gov/tb/statistics/reports/2012/pdf/report2012.pdf.,OADS,/arxiv_data1/oa_pdf/1a/e2/JGID-7-45.PMC4338454.pdf
Available at: http://medind.nic.in/maa/t05/i4/maat05i4p326.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1a/e2/JGID-7-45.PMC4338454.pdf
Available from:  http://www.who.int/tb/features_archives/policy_statement.pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/ce/JGID-7-5.PMC4338458.pdf
Available from: http://www.bd.com/ds/technicalcenter/inserts/ PP118JAA(201006)/pdf.,Non-OADS,/arxiv_data1/oa_pdf/8d/ce/JGID-7-5.PMC4338458.pdf
Available from: http://www.qiagen.com/ products/catalog/sample-technologies/dna-sample-technologies/genomic- dna/qiaamp-dna-mini-kit.,OADS,/arxiv_data1/oa_pdf/8d/ce/JGID-7-5.PMC4338458.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comBook Review Handbook of neurological sports medicine concussion and   other nervous system injuries in the athlete Joseph C. Maroon Department of Neurosurgery, University of Pittsburgh Medical Center, Suite 5C, 200 Lothrop St., Pittsburgh, PA, USA E‑mail: *Joseph C. Maroon ‑ maroonjc@upmc.edu   *Corresponding author Received: 29 October 14  Accepted: 29 October 14  Published: 12 February 15  The authors of this text, authorities in sports medicine,  have compiled one of the most all – inclusive and  comprehensive books on the diagnosis and management  of neurological sports injuries available.",Non-OADS,/arxiv_data1/oa_pdf/42/67/SNI-6-23.PMC4338479.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/23/151287 Copyright: © 2015 Maroon JC.,Non-OADS,/arxiv_data1/oa_pdf/42/67/SNI-6-23.PMC4338479.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/2/150252 Abstract Introduction: For decades cellular differentials have been generated exclusively  on analog tabletop cell counters.,Non-OADS,/arxiv_data1/oa_pdf/95/63/JPI-6-2.PMC4338481.pdf
"J Pathol Inform 2015, 1:2  http://www.jpathinformatics.org/content/6/1/2software,[8] and other approaches, manual cell counting  remains the gold standard for many of these applications.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JPI-6-2.PMC4338481.pdf
"After preliminary data had  suggested that no systematic differences existed between  digital and analog device‑generated data, the app was  made publicly available at: https://play.google.com/store/ apps/details?id=edu.sjsu.hemepathcounter.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JPI-6-2.PMC4338481.pdf
Additional images  are available at https://play.google.com/store/apps/details?id=edu.,Non-OADS,/arxiv_data1/oa_pdf/95/63/JPI-6-2.PMC4338481.pdf
"J Pathol Inform 2015, 1:2  http://www.jpathinformatics.org/content/6/1/2de‑identified patient samples.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JPI-6-2.PMC4338481.pdf
"J Pathol Inform 2015, 1:2  http://www.jpathinformatics.org/content/6/1/2two methods, and the values from the analog‑ and app‑based  methods never differed by an absolute value >3%.",OADS,/arxiv_data1/oa_pdf/95/63/JPI-6-2.PMC4338481.pdf
"J Pathol Inform 2015, 1:2  http://www.jpathinformatics.org/content/6/1/2panels]; and were not found to significantly differ by  paired t‑tests (all  P > 0.05).",OADS,/arxiv_data1/oa_pdf/95/63/JPI-6-2.PMC4338481.pdf
"J Pathol Inform 2015, 1:2  http://www.jpathinformatics.org/content/6/1/2generated by four different users on three separate  touchscreen devices.",Non-OADS,/arxiv_data1/oa_pdf/95/63/JPI-6-2.PMC4338481.pdf
"Surgical Neurology International Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology InternationalS85Treatment of Gliomas: How did we get here?",Non-OADS,/arxiv_data1/oa_pdf/e8/15/SNI-6-85.PMC4338482.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/2/85/151348,Non-OADS,/arxiv_data1/oa_pdf/e8/15/SNI-6-85.PMC4338482.pdf
"Surgical Neurology International Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology InternationalS45Bionanotechnology and the Future of Glioma Peter A. Chiarelli1, Forrest M. Kievit1, Miqin Zhang1,2, Richard G. Ellenbogen1* 1Department of Neurological Surgery, 2Department of Materials Science and Engineering, University of Washington, Seattle, Washington 98195, USA  E‑mail:  Peter A. Chiarelli ‑ pac47@uw .edu; Forrest M. Kievit ‑ fmkemt@uw .edu; Miqin Zhang ‑ mzhang@u.washington.edu;   *Richard G. Ellenbogen ‑ rge@uw .edu   *Corresponding author Received: 13 October 14   Accepted: 15 October 14  Published: 13 February 15 nanoscaled assembly, specific materials are included  to provide desired properties such as eluding immune  recognition, crossing of biological barriers, providing  contrast in medical imaging, tumor targeting, releasing  a drug, or delivering gene therapy.",Non-OADS,/arxiv_data1/oa_pdf/13/6c/SNI-6-45.PMC4338483.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/2/45/151334 INTRODUCTION The ability to manipulate atoms, design supramolecular  structures, and generate useful function at the nanoscale  provides exciting opportunities for the treatment of  human disease.",Non-OADS,/arxiv_data1/oa_pdf/13/6c/SNI-6-45.PMC4338483.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT00769093;  [Last  accessed on 2014 Aug 01].,Non-OADS,/arxiv_data1/oa_pdf/13/6c/SNI-6-45.PMC4338483.pdf
Available from: http://clinicaltrials.gov/show/NCT01563614;  [Last  accessed on 2014 Aug 01].,Non-OADS,/arxiv_data1/oa_pdf/13/6c/SNI-6-45.PMC4338483.pdf
Available from: http://clinicaltrials.gov/ct2/ show/NCT01645839;  [Last accessed on 2014 Aug 01].,Non-OADS,/arxiv_data1/oa_pdf/13/6c/SNI-6-45.PMC4338483.pdf
Magnetic Resonance (MR) Imaging Study Using Ferumoxytol  to Assess Early T umor Response in Patients With Glioblastoma Multiforme  Available from: http://clinicaltrials.gov/ct2/show/NCT00660543;  [Last  accessed on 2014 Aug 01].,Non-OADS,/arxiv_data1/oa_pdf/13/6c/SNI-6-45.PMC4338483.pdf
Available  from: http://clinicaltrials.gov/ct2/show/NCT01812746;  [Last accessed on  2014 Aug 01].,Non-OADS,/arxiv_data1/oa_pdf/13/6c/SNI-6-45.PMC4338483.pdf
Available  from http://clinicaltrials.gov/ct2/show/NCT01682746;  [Last accessed on  2014 Aug 01].,Non-OADS,/arxiv_data1/oa_pdf/13/6c/SNI-6-45.PMC4338483.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comLetter to the Editor How has the nationwide use of off‑label experimental  endovascular devices been allowed for two decades as first  choice and sometimes the only alternative to conventional  standard and advanced surgical techniques?",Non-OADS,/arxiv_data1/oa_pdf/ae/ae/SNI-6-22.PMC4338484.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/22/151262 Copyright: © 2015 Ghaly RF.,Non-OADS,/arxiv_data1/oa_pdf/ae/ae/SNI-6-22.PMC4338484.pdf
"Surgical Neurology International 2015, 6:22  http://www.surgicalneurologyint.com/content/6/1/22such results in our patients?",Non-OADS,/arxiv_data1/oa_pdf/ae/ae/SNI-6-22.PMC4338484.pdf
"Surgical Neurology International 2015, 6:22  http://www.surgicalneurologyint.com/content/6/1/22with remarkable results.",Non-OADS,/arxiv_data1/oa_pdf/ae/ae/SNI-6-22.PMC4338484.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Posterior clinoid meningioma: A case report with discussion on  terminology and surgical approach Harsimrat Bir S. Sodhi, Navneet Singla, Sunil K. Gupta Department of Neurosurgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India E‑mail: *Harsimrat Bir S. Sodhi  ‑ harsimrat_sodhi@rediffmail.com; Navneet Singla  ‑ drnavi2007@gmail.com; Sunil K. Gupta  ‑ drguptasunil@gmail.com   *Corresponding author Received: 29  August 14   Accepted: 12  No vember 14   Published: 11 F ebruary 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.151261  Quick Response Code: Abstract Background:  Posterior clinoid process  (PCP) meningiomas are rare lesions.",Non-OADS,/arxiv_data1/oa_pdf/04/7d/SNI-6-21.PMC4338485.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/21/151261 Copyright: © 2015 Sodhi HBS.,Non-OADS,/arxiv_data1/oa_pdf/04/7d/SNI-6-21.PMC4338485.pdf
"Surgical Neurology International 2014, 5:21  http://www.surgicalneurologyint.com/content/5/1/21MR angiography, the tumor was displacing the right P1  and P2 segments posteriorly and the ICA was displaced  anteriorly and laterally  [Figure  2a].",Non-OADS,/arxiv_data1/oa_pdf/04/7d/SNI-6-21.PMC4338485.pdf
"Surgical Neurology International 2014, 5:21  http://www.surgicalneurologyint.com/content/5/1/21meningioma.",Non-OADS,/arxiv_data1/oa_pdf/04/7d/SNI-6-21.PMC4338485.pdf
"Surgical Neurology International 2014, 5:21  http://www.surgicalneurologyint.com/content/5/1/21Commentary The Authors report a case of meningioma with  implant base in the right posterior clinoid process (PCP) successfully treated through a fronto‑ temporo‑orbito‑zygomatic (FTOZ) approach.",Non-OADS,/arxiv_data1/oa_pdf/04/7d/SNI-6-21.PMC4338485.pdf
"Surgical Neurology International 2014, 5:21  http://www.surgicalneurologyint.com/content/5/1/21resection of the lesion through a pterional approach    [Figures  1 and 2].",Non-OADS,/arxiv_data1/oa_pdf/04/7d/SNI-6-21.PMC4338485.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comLetter to the Editor Neuroethics are more than the bioethics of neuroscience Rodrigo Ramos‑Zúñiga Department of Neurosciences, Institute of Translational Neurosciences, CUCS University of Guadalajara, México E‑mail: *Rodrigo Ramos‑Zúñiga ‑ rodrigorz13@gmail.com   *Corresponding author Received: 11 November 14  Accepted: 24 November 14  Published: 12 February 15  Dear Sir, Evolutionary changes in the knowledge society and the  rapid increase of scientific and technological information  have outlined new territories and dilemmas for health  professionals.",Non-OADS,/arxiv_data1/oa_pdf/97/01/SNI-6-24.PMC4338486.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/24/151288 Copyright: © 2015 Ramos‑Zúñiga R. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/97/01/SNI-6-24.PMC4338486.pdf
"Surgical Neurology International 2015, 6:24  http://www.surgicalneurologyint.com/content/6/1/24the branches of knowledge in current neurosciences and  proposes an ethics of Neuroscience.",Non-OADS,/arxiv_data1/oa_pdf/97/01/SNI-6-24.PMC4338486.pdf
"Surgical Neurology International Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology InternationalS59Convection‑enhanced drug delivery for gliomas Andrew T .",Non-OADS,/arxiv_data1/oa_pdf/68/87/SNI-6-59.PMC4338487.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/2/59/151337 Access this article  online Website: www.surgicalneurologyint.com DOI: 10.4103/2152-7806.151337  Quick Response Code:,Non-OADS,/arxiv_data1/oa_pdf/68/87/SNI-6-59.PMC4338487.pdf
"Surgical Neurology International Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology InternationalS78Interstitial chemotherapy for malignant glioma: Future prospects  in the era of multimodal therapy Antonella Mangraviti1, Betty T yler1, Henry Brem1,2,3,4 1Departments of Neurosurgery, 2Oncology, 3Ophthalmology, and 4Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland,  USA E‑mail: *Betty Tyler ‑ btyler@jhmi.edu; Antonella Mangraviti ‑ amangra1@jhmi.edu; Henry Brem ‑ hbrem@jhmi.edu   *Corresponding author Received: 05 August 14   Accepted: 15 October 14  Published: 13 February 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.151345  Quick Response Code: Abstract The advent of interstitial chemotherapy has significantly increased therapeutic  options for patients with malignant glioma.",Non-OADS,/arxiv_data1/oa_pdf/52/eb/SNI-6-78.PMC4338488.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/2/78/151345 Copyright: © 2015 Mangraviti A.,Non-OADS,/arxiv_data1/oa_pdf/52/eb/SNI-6-78.PMC4338488.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Surgical technique for repair of complex anterior skull base  defects Kevin Reinard, Azam Basheer, Lamont Jones1, Robert Standring1, Ian Lee, Jack Rock Departments of Neurosurgery, and 1Otorhinolaryngology, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202, USA E‑mail: *Kevin Reinard ‑ kreinar1@hfhs.org; Azam Basheer ‑ abashee1@hfhs.org; Lamont Jones ‑ ljones5@hfhs.org; Robert Standring ‑ rstandr1@hfhs.org;   Ian Lee ‑ ilee1@hfhs.org; Jack Rock ‑ jrock1@hfhs.org   *Corresponding author Received: 03 July 14  Accepted: 11 December 14  Published: 11 February 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.151259  Quick Response Code: Abstract Background:  Modern microsurgical techniques enable en bloc  resection of  complex skull base tumors.",Non-OADS,/arxiv_data1/oa_pdf/a8/94/SNI-6-20.PMC4338489.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/20/151259,Non-OADS,/arxiv_data1/oa_pdf/a8/94/SNI-6-20.PMC4338489.pdf
"Surgical Neurology International 2015, 6:20  http://www.surgicalneurologyint.com/content/6/1/20on a watertight dural closure to prevent postoperative  CSF leak that could complicate up to 41% of cases.",Non-OADS,/arxiv_data1/oa_pdf/a8/94/SNI-6-20.PMC4338489.pdf
"Surgical Neurology International 2015, 6:20  http://www.surgicalneurologyint.com/content/6/1/20Postoperative expansion of the frontal lobe over the  layered reconstruction of dura and bony anterior cranial  fossa floor provides additional support by reinforcing  the watertight seal [Figure 3 left panel, Figure 5].",Non-OADS,/arxiv_data1/oa_pdf/a8/94/SNI-6-20.PMC4338489.pdf
"Surgical Neurology International 2015, 6:20  http://www.surgicalneurologyint.com/content/6/1/20ranging from no formal reconstruction to elaborate free  flaps with microvascular anastomosis.",Non-OADS,/arxiv_data1/oa_pdf/a8/94/SNI-6-20.PMC4338489.pdf
"Surgical Neurology International 2015, 6:20  http://www.surgicalneurologyint.com/content/6/1/20fossa floor because our primary objective is to buttress  the frontal dural repair.",Non-OADS,/arxiv_data1/oa_pdf/a8/94/SNI-6-20.PMC4338489.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Factors affecting ventriculoperitoneal shunt survival in adult  patients Farid Khan, Abdul Rehman1, Muhammad S. Shamim, Muhammad E. Bari Departments of Surgery and 1Biological and Biomedical Sciences, The Aga Khan University, Stadium Road, Karachi, Sindh, Pakistan E‑mail:  Farid Khan ‑ drfaridkhan@hotmail.com; Abdul Rehman ‑ jsmawais@yahoo.com; Muhammad S. Shamim ‑ shahzad.shamim@aku.edu;   *Muhammad E. Bari ‑ ehsan.bari@aku.edu   *Corresponding author Received: 26 April 14  Accepted: 09 October 14  Published: 13 February 15  Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.151388  Quick Response Code: Abstract Background:  Ventriculoperitoneal (VP) shunt insertion remains the mainstay of  treatment for hydrocephalus despite a high rate of complications.",Non-OADS,/arxiv_data1/oa_pdf/5e/c4/SNI-6-25.PMC4338490.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/25/151388 Copyright: © 2015 Khan F .,Non-OADS,/arxiv_data1/oa_pdf/5e/c4/SNI-6-25.PMC4338490.pdf
"Surgical Neurology International 2015, 6:25  http://www.surgicalneurologyint.com/content/6/1/251‑year failure rate for VP shunts had been reported at  around 40‑50% for pediatric patients and 29% for adults  until a few decades ago.",Non-OADS,/arxiv_data1/oa_pdf/5e/c4/SNI-6-25.PMC4338490.pdf
"Surgical Neurology International 2015, 6:25  http://www.surgicalneurologyint.com/content/6/1/25included in our study was 45.8 years, ranging from a  minimum of 18 years to a maximum of 85 years.",Non-OADS,/arxiv_data1/oa_pdf/5e/c4/SNI-6-25.PMC4338490.pdf
"Surgical Neurology International 2015, 6:25  http://www.surgicalneurologyint.com/content/6/1/257.0%), cerebellopontine angle (n = 15, 6.6%) and supra‑ or  parasellar (n = 9, 4.0%) region were the most common sites  for tumors.",Non-OADS,/arxiv_data1/oa_pdf/5e/c4/SNI-6-25.PMC4338490.pdf
"Surgical Neurology International 2015, 6:25  http://www.surgicalneurologyint.com/content/6/1/25underwent shunt revision.",Non-OADS,/arxiv_data1/oa_pdf/5e/c4/SNI-6-25.PMC4338490.pdf
"Surgical Neurology International 2015, 6:25  http://www.surgicalneurologyint.com/content/6/1/25placement to first shunt failure between the different  types of brain tumor ( P = 0.062, log‑rank test) and the  different locations of brain tumor (P = 0.378, log‑rank  test) failed to reach statistical significance.",Non-OADS,/arxiv_data1/oa_pdf/5e/c4/SNI-6-25.PMC4338490.pdf
"Surgical Neurology International 2015, 6:25  http://www.surgicalneurologyint.com/content/6/1/25of the choroid plexus and other nearby tissues during  the surgical procedure.",Non-OADS,/arxiv_data1/oa_pdf/5e/c4/SNI-6-25.PMC4338490.pdf
"Surgical Neurology International 2015, 6:25  http://www.surgicalneurologyint.com/content/6/1/25REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/5e/c4/SNI-6-25.PMC4338490.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/1/150246 Abstract Background:  Little evidence is available concerning the impact of virtual microscopy  (VM) in the undergraduate teaching of pathology.,Non-OADS,/arxiv_data1/oa_pdf/b7/be/JPI-6-1.PMC4338491.pdf
"J Pathol Inform 2015, 1:1  http://www.jpathinformatics.org/content/6/1/1way in which these disciplines can be delivered online  by providing the ability to scan entire glass slides at  diagnostic resolution.",Non-OADS,/arxiv_data1/oa_pdf/b7/be/JPI-6-1.PMC4338491.pdf
"J Pathol Inform 2015, 1:1  http://www.jpathinformatics.org/content/6/1/1software installation is required to visualize the virtual slides.",Non-OADS,/arxiv_data1/oa_pdf/b7/be/JPI-6-1.PMC4338491.pdf
"The survey was designed  using the free website https://www.surveymonkey.com/ (SurveyMonkey®, Menlo Park, CA, USA) and was posted  as an online hyperlink on the Moodle platform, which  remained open for a whole week after the online exam  was completed.",OADS,/arxiv_data1/oa_pdf/b7/be/JPI-6-1.PMC4338491.pdf
"J Pathol Inform 2015, 1:1  http://www.jpathinformatics.org/content/6/1/1Audit of Student Accesses to the Viewer The number of visits to the VM from the opening of the  website to the day of the exam is shown in Figure 2; about  80.3% of the accesses (862/1073) were done in the week  prior to the examination; 57.5% of the visits were made on  holidays and 42.5% on working days.",Non-OADS,/arxiv_data1/oa_pdf/b7/be/JPI-6-1.PMC4338491.pdf
"J Pathol Inform 2015, 1:1  http://www.jpathinformatics.org/content/6/1/1time.",Non-OADS,/arxiv_data1/oa_pdf/b7/be/JPI-6-1.PMC4338491.pdf
"J Pathol Inform 2015, 1:1  http://www.jpathinformatics.org/content/6/1/1The main strength of our study is that it allows  adequate comparison of two very similar groups from  the same course working with the same material and  that it provides objective data on how students learn  pathology.",Non-OADS,/arxiv_data1/oa_pdf/b7/be/JPI-6-1.PMC4338491.pdf
"Surgical Neurology International Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology InternationalS89Personalized Medicine for Gliomas Chibawanye I. Ene1, Eric C. Holland1,2,3 1Department of Neurological Surgery, University of Washington School of Medicine, 2Human Biology Division, Fred Hutchinson Cancer Research Center, 3Alvord  Brain Tumor Center, University of Washington, Seattle, Washington, U.S.A E‑mail: Chibawanye I. Ene ‑ chiba@uw .edu, *Eric C. Holland ‑ eholland@fhcrc.org   *Corresponding author Received: 02 April 14   Accepted: 12 August 14   Published: 13 F ebruary 15 INTRODUCTION Personalized medicine for cancer entails tailoring therapy  for each patient based on genomic or epigenomic mutations unique to the tumor.",Non-OADS,/arxiv_data1/oa_pdf/ee/b2/SNI-6-89.PMC4338492.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/2/89/151351 Copyright: © 2015 Ene CI.,Non-OADS,/arxiv_data1/oa_pdf/ee/b2/SNI-6-89.PMC4338492.pdf
Available FREE in open access from: http://www.jpathinformatics.org/text.asp?2015/6/1/3/150256 Abstract Requisition storage and retrieval are an integral part of the outpatient laboratory  testing process.,Non-OADS,/arxiv_data1/oa_pdf/39/8c/JPI-6-3.PMC4338493.pdf
"J Pathol Inform 2015, 1:3  http://www.jpathinformatics.org/content/6/1/3physician, demographic information in question, unusual  test‑request or test combination, question from referring  laboratory, possible specimen mix‑up), we would manually  retrieve the paper requisition from filing cabinets located  in the accessioning area by date.",Non-OADS,/arxiv_data1/oa_pdf/39/8c/JPI-6-3.PMC4338493.pdf
"J Pathol Inform 2015, 1:3  http://www.jpathinformatics.org/content/6/1/3barcodes using libdmtx but, unlike the other symbologies  implemented through ZBar, currently this is not searching  for multiple Data Matrix barcodes per page.",Non-OADS,/arxiv_data1/oa_pdf/39/8c/JPI-6-3.PMC4338493.pdf
"J Pathol Inform 2015, 1:3  http://www.jpathinformatics.org/content/6/1/3resolution, 97.6% at 500 DPI, 94.9% at 400 DPI and 78.2%  at 300 DPI.",Non-OADS,/arxiv_data1/oa_pdf/39/8c/JPI-6-3.PMC4338493.pdf
"J Pathol Inform 2015, 1:3  http://www.jpathinformatics.org/content/6/1/3order‑entry error and that 10% of institutions had errors  with at least 18% of requisitions.",OADS,/arxiv_data1/oa_pdf/39/8c/JPI-6-3.PMC4338493.pdf
Available from: http://www.zbar.,Non-OADS,/arxiv_data1/oa_pdf/39/8c/JPI-6-3.PMC4338493.pdf
Available from: https://www.pdflabs.com/ tools/pdftk‑the‑pdf‑toolkit.Last accessed 2014 Nov 19.,Non-OADS,/arxiv_data1/oa_pdf/39/8c/JPI-6-3.PMC4338493.pdf
"J Pathol Inform 2015, 1:3  http://www.jpathinformatics.org/content/6/1/3Determination of serum aldosterone by liquid chromatography and tandem  mass spectrometry: A liquid‑liquid extraction method for the ABSCIEX  API‑5000 mass spectrometry system.",OADS,/arxiv_data1/oa_pdf/39/8c/JPI-6-3.PMC4338493.pdf
"Surgical Neurology International Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology InternationalS68Immunotherapy for malignant glioma Carter M. Suryadevara1,2,3, Terence Verla1,3, Luis Sanchez‑Perez1,3, Elizabeth A. Reap1,3,   Bryan D. Choi4, Peter E. Fecci1,3, John H. Sampson1,2,3 1Duke Brain Tumor Immunotherapy Program, Division of Neurosurgery, Department of Surgery, 2Department of Pathology, 3The Preston Robert Tisch Brain Tumor  Center, Duke University Medical Center, Durham, NC 27710, 4Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston,  MA 02114, USA E‑mail: *Carter M. Suryadevara ‑ carter.suryadevara@duke.edu; T erence Verla ‑ terence.verla@duke.edu; Luis Sanchez‑Perez ‑ luis.sanchez‑perez@duke.edu;   Elizabeth A.",Non-OADS,/arxiv_data1/oa_pdf/0b/ac/SNI-6-68.PMC4338494.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/2/68/151341,Non-OADS,/arxiv_data1/oa_pdf/0b/ac/SNI-6-68.PMC4338494.pdf
"Surgical Neurology International Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology InternationalS9The future of high‑grade glioma: Where we are and where are we  going Emilie Le Rhun, Sophie Taillibert1, Marc C. Chamberlain2 Department of Neuro‑oncology, Roger Salengro Hospital, University Hospital, Lille, and Neurology, Department of Medical Oncology, Oscar Lambret Center,  Lille, France, Inserm U‑1192, Laboratoire de Protéomique, Réponse Inflammatoire, Spectrométrie de Masse (PRISM), Lille 1 University, Villeneuve D’Ascq,  France, 1Neurology, Mazarin and Radiation Oncology, Pitié‑Salpétrière Hospital, University Pierre et Marie Curie, Paris VI, Paris, France, 2Department of  Neurology and Neurological Surgery, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, WA, USA  E‑mail:  Emilie Le Rhun ‑ emilie.lerhun@chru‑lille.fr; Sophie Taillibert ‑ sophie.taillibert@gmail.com; *Marc C. Chamberlain ‑ chambemc@u.washington.edu   *Corresponding author Received: 16 May 14   Accepted: 15 October 14  Published: 13 February 15 Copyright: © 2015 Le Rhun E. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.This article may be cited as:   Rhun EL, Taillibert S, Chamberlain MC.",Non-OADS,/arxiv_data1/oa_pdf/ee/1b/SNI-6-9.PMC4338495.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/2/9/151331 Abstract High‑grade glioma (HGG) are optimally treated with maximum safe surgery,  followed by radiotherapy (RT) and/or systemic chemotherapy (CT).",Non-OADS,/arxiv_data1/oa_pdf/ee/1b/SNI-6-9.PMC4338495.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report A rare case of giant cell tumor involving the clivus resected  through Le Fort I Osteotomy and median maxillotomy Julie Le, Kongkrit Chaiyasate1, Kliment Donev2, Daniel K. Fahim Departments of Neurosurgery, 1Plastic and Reconstructive Surgery, and 2Pathology, Oakland University William Beaumont School of Medicine, Royal Oak,  Michigan, USA  E‑mail:  Julie Le – jle2@oakland.edu; Kongkrit Chaiyasate ‑ kongkrit.chaiyasate@beaumont.edu; Kliment Donev ‑ Kliment.Donev@beaumont.edu;  *Daniel K. Fahim ‑ Daniel.Fahim@beaumont.edu   *Corresponding author Received: 27 July 14  Accepted: 03 December 14  Published: 13 February 15  Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.151393  Quick Response Code: Abstract Background:  Giant cell tumors (GCTs) are bone tumors that seldom involve the  skull.",Non-OADS,/arxiv_data1/oa_pdf/5f/61/SNI-6-26.PMC4338496.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/26/151393 Copyright: © 2015 Le J.,Non-OADS,/arxiv_data1/oa_pdf/5f/61/SNI-6-26.PMC4338496.pdf
"Surgical Neurology International 2015, 6:26  http://www.surgicalneurologyint.com/content/6/1/26Management and outcome Given the atypical appearance of this lesion, a transnasal  endoscopic transsphenoidal biopsy was performed  for tumor diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/5f/61/SNI-6-26.PMC4338496.pdf
"Surgical Neurology International 2015, 6:26  http://www.surgicalneurologyint.com/content/6/1/26advanced 7 days after surgery.",Non-OADS,/arxiv_data1/oa_pdf/5f/61/SNI-6-26.PMC4338496.pdf
"Surgical Neurology International 2015, 6:26  http://www.surgicalneurologyint.com/content/6/1/26reconstruction of the maxillofacial osteotomies is  essential to achieve excellent cosmesis and avoid  malocclusion.",Non-OADS,/arxiv_data1/oa_pdf/5f/61/SNI-6-26.PMC4338496.pdf
"Surgical Neurology International Editor: Daniel Silbergeld,  University  of Washington Medical Center,  Seattle, Washington, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neuro-Oncology, a supplement to Surgical Neurology InternationalS1Robotics in the neurosurgical treatment of glioma Garnette R. Sutherland, Yaser Maddahi, Liu Shi Gan, Sanju Lama, Kourosh Zareinia Project NeuroArm, Department of Clinical Neuroscience and The Hotchkiss Brain Institute, University of Calgary, 3280 Hospital Dr NW , Calgary, AB T2N 4Z6,  Canada E‑mail: *Garnette Sutherland ‑ garnette@ucalgary.ca;   Yaser Maddahi ‑ ymaddahi@ucalgary.ca; Liu Shi Gan ‑ lsgan@ucalgary.ca; Sanju Lama ‑ slama@ucalgary.ca;  Kourosh Zareinia ‑ kzareini@ucalgary.ca   *Corresponding author Received: 01 August 14  Accepted: 15 October 14  Published: 13 February 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.151321  Quick Response Code: Abstract Background: The treatment of glioma remains a significant challenge with high  recurrence rates, morbidity, and mortality.",Non-OADS,/arxiv_data1/oa_pdf/e2/a9/SNI-6-1.PMC4338497.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/2/1/151321 Copyright: © 2015 Sutherland GR.,Non-OADS,/arxiv_data1/oa_pdf/e2/a9/SNI-6-1.PMC4338497.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/20/d4/ijem-13-01-19511.PMC4338645.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.For early detection and optimized management of thy - roid dysfunction before and during pregnancy , we have  to look at four levels of prevention: primordial, primary ,  secondary , and tertiary .",Non-OADS,/arxiv_data1/oa_pdf/81/5e/ijem-13-01-25728.PMC4338646.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/56/83/ijem-12-04-15806.PMC4338647.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/41/10/ijem-13-01-17570.PMC4338648.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/2c/d1/ijem-12-04-18642.PMC4338650.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/b4/b4/ijem-12-04-19378.PMC4338651.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/84/f8/ijem-12-04-18081.PMC4338652.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e6/10/ijem-13-01-18791.PMC4338653.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/90/6c/ijem-13-01-17988.PMC4338654.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/fb/69/ijem-12-04-18980.PMC4338665.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/2e/e1/ijem-13-01-22604.PMC4338666.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate- rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1f/d6/ijem-13-01-18220.PMC4338667.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/30/1e/ijem-13-01-20620.PMC4338668.pdf
"This is an open-access article distributed under the terms of the Creative  Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the mate - rial just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/dc/c6/ijem-13-01-21160.PMC4338669.pdf
"This is an open-access article distributed under the  terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and  redistribute the material just in noncommercial usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/0c/71/ijem-12-04-16429.PMC4338670.pdf
The online version of the art icle has been updated and is available at http://jaha.ahajournals.org/content/3/4/e001005.,Non-OADS,/arxiv_data1/oa_pdf/3b/b5/jah3-3-e000512.PMC4338681.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/3/5/ e001197.,Non-OADS,/arxiv_data1/oa_pdf/a9/11/jah3-3-e000522.PMC4338682.pdf
A user-friendly calculator to assess the 20-year risk of CVD based on the Healthy Heart Score is freely accessible at http://www.healthyheartscore.org.,Non-OADS,/arxiv_data1/oa_pdf/63/7b/jah3-3-e000954.PMC4338684.pdf
"Accompanying Figures S1 –S4 are available at http://jaha.ahajournals.org/ content/3/6/e000963/suppl/DC1 Correspondence: Brijesh P. Mehta, MD, Memorial Neuroscience Institute, 3501 Johnson Street, Hollywood, FL 33021.",Non-OADS,/arxiv_data1/oa_pdf/0b/6a/jah3-3-e000963.PMC4338685.pdf
Accompanying Data S1 is available at http://jaha.ahajournals.org/content/ 3/6/e000979/suppl/DC1.,OADS,/arxiv_data1/oa_pdf/6e/29/jah3-3-e000979.PMC4338686.pdf
Available at http://www.hcup-us.ahrq.gov/toolssoftware/ccs.ccs.jsp.,OADS,/arxiv_data1/oa_pdf/f2/c9/jah3-3-e001057.PMC4338692.pdf
"Available at http://www.bls.gov/cpi/ cpifact8.htm (Accessed May 10, 2014).",Non-OADS,/arxiv_data1/oa_pdf/f2/c9/jah3-3-e001057.PMC4338692.pdf
A set of 5 housekeeping genes was included in each experiment.The relative gene expression of the genes was calculated using an online data analysis tool (http://pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php).,OADS,/arxiv_data1/oa_pdf/b8/de/jah3-3-e001064.PMC4338693.pdf
"In accordance with Minimum Information About a Microarray Experiment (MIAME) guidelines, the annotation for the Affymetrix microarray is available at: http://www.mge- d.org/Workgroups/MIAME/miame_1.1.html.",OADS,/arxiv_data1/oa_pdf/9d/59/jah3-3-e001104.PMC4338699.pdf
Statistical Analysis Admission rates We calculated crude admission rates per 100 000 person- years using population data for each year of our study period as denominators (http://www.abs.gov.au/AUSSTATS/ abs@.nsf/DetailsPage/3201.0Jun%202009?OpenDocument).,Non-OADS,/arxiv_data1/oa_pdf/7d/f0/jah3-3-e001161.PMC4338703.pdf
"Participation is a legal requirement and approaches 100% (eg, 95.8% in the 2006 census; http://www.abs.gov.au/webs- itedbs/censushome.nsf/home/nonresponserates).",Non-OADS,/arxiv_data1/oa_pdf/7d/f0/jah3-3-e001161.PMC4338703.pdf
Region-of-birth groupings wereassigned using a standard classi ﬁcation (http://www.abs.go- v.au/ausstats/abs@.nsf/Loo kup/1269.0main+features102011).,OADS,/arxiv_data1/oa_pdf/7d/f0/jah3-3-e001161.PMC4338703.pdf
"A series of state government task forces particularly addressed equitable access to stroke services and providedadditional funding and resources linked to evidence-based practices and pathways beginning in emergency departments to ensure that patients with focal neurological symptoms, syncope, and headaches were directed to specialist inpa- tient services 68(http://www.aci.health.nsw.gov.au/networks/ stroke/about).",Non-OADS,/arxiv_data1/oa_pdf/7d/f0/jah3-3-e001161.PMC4338703.pdf
Available at: http://www.cherel.org.au/quality-assurance.,Non-OADS,/arxiv_data1/oa_pdf/7d/f0/jah3-3-e001161.PMC4338703.pdf
Available at: http://www.abs.,Non-OADS,/arxiv_data1/oa_pdf/7d/f0/jah3-3-e001161.PMC4338703.pdf
Available at: http://www.healthstats.nsw.,Non-OADS,/arxiv_data1/oa_pdf/7d/f0/jah3-3-e001161.PMC4338703.pdf
A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.,Non-OADS,/arxiv_data1/oa_pdf/8c/b8/jah3-3-e001223.PMC4338707.pdf
Available from: http://www.who.int/classi ﬁca- tions/icd/icdonlineversions/en/.,OADS,/arxiv_data1/oa_pdf/69/13/jah3-3-e001236.PMC4338710.pdf
Available at: http://www.ssb.no/a/publikasjoner/pdf/rapp_200905.pdf.,Non-OADS,/arxiv_data1/oa_pdf/69/13/jah3-3-e001236.PMC4338710.pdf
Available at: http://www.ssb.no/helse/statistikker/dodsarsak/aar/ 2011-10-14.,OADS,/arxiv_data1/oa_pdf/69/13/jah3-3-e001236.PMC4338710.pdf
Available at: http://www.who.int/chp/knowledge/publica- tions/adherence_report/en/.,Non-OADS,/arxiv_data1/oa_pdf/69/13/jah3-3-e001236.PMC4338710.pdf
"Accompanying Video clips S1 and S2 are available at http://jaha.ahajournals.org/content/3/5/e001263/suppl/DC1Correspondence to: Shinsuke Yuasa, MD, PhD, Department of Cardiology, Keio University school of Medicine, 35-Shinanomachi Shinjuku-ku, Tokyo, Japan, 160-8582.",Non-OADS,/arxiv_data1/oa_pdf/1d/9d/jah3-3-e001263.PMC4338713.pdf
Available at: http://www.cdc.gov/nchs/fastats/docvisit.htm.,OADS,/arxiv_data1/oa_pdf/25/f2/jah3-3-e001268.PMC4338714.pdf
A full list of participating MESAinvestigators and institutions can be found at http://www.mesa-nhlbi.org.,Non-OADS,/arxiv_data1/oa_pdf/23/9a/jah3-3-e001270.PMC4338716.pdf
"All analyses were conducted with R Core Team (2013) R: A language and environment for statistical computing (RFoundation for Statistical Computing, Vienna, Austria, URL http://www.R-project.org/).",OADS,/arxiv_data1/oa_pdf/c7/74/jah3-3-e001278.PMC4338718.pdf
A full list of participating MESA investigators and institutions can be found at http://www.mesa-nhlbi.org.,Non-OADS,/arxiv_data1/oa_pdf/c7/74/jah3-3-e001278.PMC4338718.pdf
"36. http://www.ncbi.nlm.nih.gov/books/NKD56070/ Accessed 18 November, 2014.",Non-OADS,/arxiv_data1/oa_pdf/c7/74/jah3-3-e001278.PMC4338718.pdf
"Primers were designed with Primer BLAST software(http://www.ncbi.nlm.nih.gov/tools/primer-blast) for Atg5, Lc3a, Lc3b, Becn1, Ppargc1a, and Sirt1 genes or purchased using commercially available TaqMan Gene Expression Assays (Applied Biosystems) for Bax, Bcl2, Cat, Gpx1, and Sod2 genes.",OADS,/arxiv_data1/oa_pdf/5f/69/jah3-3-e001329.PMC4338726.pdf
Data were normalized to the values for the housekeeping genes panel using a DDCt method and analyzed by online RT2Proﬁler PCR Array Data Analysis Software (http://www.pcrdataanalysis.sabioscienc- es.com/pcr/arrayanalysis.php).,OADS,/arxiv_data1/oa_pdf/5f/69/jah3-3-e001329.PMC4338726.pdf
Available at: http://www.iom.edu/Reports/2009/ComparativeEffec- tivenessResearchPriorities.aspx.,Non-OADS,/arxiv_data1/oa_pdf/24/cd/jah3-3-e001330.PMC4338727.pdf
Available at: http://njdatabank.newark.rutgers.edu/special-sandy.,Non-OADS,/arxiv_data1/oa_pdf/db/6e/jah3-3-e001354.PMC4338729.pdf
Available at: http://lwd.dol.state.nj.us/labor/lpa/dmograph/est/ est_index.html.,OADS,/arxiv_data1/oa_pdf/db/6e/jah3-3-e001354.PMC4338729.pdf
Available at: http://www.state.nj.us/health/ ﬂu/ﬂuinfo.shtml.,Non-OADS,/arxiv_data1/oa_pdf/db/6e/jah3-3-e001354.PMC4338729.pdf
Available at: http://climate.rutgers.edu/statec- lim_v1/data/index.html.,OADS,/arxiv_data1/oa_pdf/db/6e/jah3-3-e001354.PMC4338729.pdf
Available at: http://www.epa.gov/airdata/index.html.,OADS,/arxiv_data1/oa_pdf/db/6e/jah3-3-e001354.PMC4338729.pdf
"*Accompanying Data S1, which lists the participating EVOLVE sites and af ﬁliated investigators, are available at http://jaha.ahajournals.org/content/3/6/ e001363/suppl/DC1 Correspondence to: Charles A. Herzog, MD, Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th St, Suite S-406, Minneapolis, MN 55404.",Non-OADS,/arxiv_data1/oa_pdf/7d/4f/jah3-3-e001363.PMC4338730.pdf
"Dr Mahaffey ’sﬁnancial disclosures prior to August 1, 2013, can be viewed at https://www.dcri.org/about-us/con ﬂict-of- interest/Mahaffey-COI_2011-2013.pdf; disclosures after August 1, 2013, can be viewed at http://med.stan- ford.edu/pro ﬁles/kenneth_mahaffey.",Non-OADS,/arxiv_data1/oa_pdf/7d/4f/jah3-3-e001363.PMC4338730.pdf
Complete de ﬁnitions of all variables were prospectively de ﬁned by an ACC committee and are available at the ACC NCDR web site (http://www.acc.org/ncdr/ cathlab.htm).,OADS,/arxiv_data1/oa_pdf/c0/cf/jah3-3-e001380.PMC4338731.pdf
"Sample contamination was assessed by sex mismatches using X-chromosome data and through heterozygosity analysis, and cryptic relatedness was estimated by pairwise identity-by-descendent analysis in PLINK (http://pngu.mgh.harvard.edu/~purcell/plink/).",OADS,/arxiv_data1/oa_pdf/99/3b/jah3-3-e001398.PMC4338734.pdf
"Statistical Analysis Association of genotyped SNPs, calculated as adjusted oddsratios (OR) and 95% CI, with RHTN was tested with multiple logistic regression analysis in INVEST European American and Hispanic race/ethnicity groups separately, under an additive genetic model using PLINK (http://pngu.mgh.harvard.edu/ purcell/plink/).",OADS,/arxiv_data1/oa_pdf/99/3b/jah3-3-e001398.PMC4338734.pdf
Available from: http://www.cdc.gov/nchs/ nhanes/about_nhanes.htm.,OADS,/arxiv_data1/oa_pdf/67/92/jah3-3-e001454.PMC4338737.pdf
"An accompanying Video S1 is available at http://jaha.ahajournals.org/ content/3/6/e001474/suppl/DC1 Correspondence to: Kalev Freeman, University of Vermont, Given E301, Burlington, VT, USA, 05405.",Non-OADS,/arxiv_data1/oa_pdf/23/ae/jah3-3-e001474.PMC4338739.pdf
"Accompanying Tables S1 through S4 are available at http://jaha.ahajour- nals.org/content/3/6/e001483/suppl/DC1The results of this study have been presented as an abstract at the American Heart Association Scienti ﬁc Sessions Nov. 16 –20, 2013 in Dallas, TX.",Non-OADS,/arxiv_data1/oa_pdf/c5/01/jah3-3-e001483.PMC4338740.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/ content/3/6/e001491/suppl/DC1 *Lin, Moungey, and Lim are joint ﬁrst authors.",OADS,/arxiv_data1/oa_pdf/5d/bf/jah3-3-e001491.PMC4338741.pdf
"In addi- tion, >30 hERG amino acid sequence variants thought to represent polymorphisms (see the Gene Connection for the Heart database at http://www.fsm.it/cardmoc/) similarly occur in the N- and C-termini mainly in non-HOS regions, although most have not been expressed and studied functionally.",Non-OADS,/arxiv_data1/oa_pdf/5d/bf/jah3-3-e001491.PMC4338741.pdf
"Additional whole-genome information was recently made available through the WTSIMGP (http://www.sanger.ac.uk/ resources/mouse/genomes/),37through which sequencing is available for at least 17 key mouse strains or substrains including BALB/cJ, C57BL/6J, C57BL/6NJ and three 129 strains or substrains.",Non-OADS,/arxiv_data1/oa_pdf/5d/bf/jah3-3-e001491.PMC4338741.pdf
"[24]   Room temperature Hall coefﬁ  cient and resistivityfor selected chem- ical elements,  http://it.stlawu.edu/~koon/HallTable.html , accessed:   December 2014  .",Non-OADS,/arxiv_data1/oa_pdf/d1/a5/adma0027-1274.PMC4338756.pdf
"[27]     S.    Mouaziz  ,   S.    Boero  ,   L.    Scandella  ,   R.    Popovic  ,   J.    Brugger  ,  presented at “Trends in Nanotechnology”(TNT 2004), Refer-ence: LMIS1-POSTER-2007-033, Segovia, Spain,   2004  ; see   http://infoscience.epﬂ  .ch/record/101340?ln =en , accessed:  December  2014 .",Non-OADS,/arxiv_data1/oa_pdf/d1/a5/adma0027-1274.PMC4338756.pdf
"Regional brain volume measurements, cortical thicknesses, and intracranial volumes were calculatedusing FreeSurfer v5.0 (http://surfer.nmr.mgh.harvard.edu/).",OADS,/arxiv_data1/oa_pdf/a4/48/ana0077-0251.PMC4338762.pdf
"Outliers were excluded by the Grubb test based on a prioridefined criteria using the GraphPad (San Diego, CA) Quick- Calcs Web site: http://www.graphpad.com/quickcalcs/ConfIn- terval1.cfm.",OADS,/arxiv_data1/oa_pdf/db/53/ana0076-0443.PMC4338764.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c0/40/dddt-9-983.PMC4338775.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 983–992Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  983Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6546 8synthesis of an anthraquinone derivative (D haQc)  and its effect on induction of g2/M arrest   and apoptosis in breast cancer McF-7 cell line sweeKeong Yeap1 Muhammad nadeem  akhtar2 Kian lam lim3 nadiah abu4,5 Wan Y ong ho6 seema Zareen2 Kiarash roohani1 huynh Ky4 sheau Wei Tan1 nordin lajis7 noorjahan Banu alitheen1,4 1institute of Bioscience, Universiti  Putra Malaysia, selangor Darul  ehsan, Malaysia;  2Faculty of industrial  sciences and Technology, Universiti  Malaysia Pahang, Kuantan, Pahang,   Malaysia;  3Faculty of Medicine and  health sciences, Universiti T unku  abdul rahman, selangor Darul ehsan,   Malaysia;  4Faculty of Biotechnology  and Biomolecular sciences, Universiti  Putra Malaysia, selangor Darul  ehsan, Malaysia;  5Bright sparks Unit,   University of Malaya, Kuala lumpur,   Malaysia; 6school of Biomedical  sciences, University of nottingham  Malaysia campus, selangor Darul  ehsan, Malaysia;  7scientific chairs Unit,   Taibah University, Medina, saudi arabia correspondence: noorjahan Banu  alitheen   Faculty of Biotechnology and  Biomolecular sciences, Universiti Putra  Malaysia, UPM 43400 serdang, selangor  Darul ehsan, Malaysia   Tel +60 3 8946 7471  Fax +60 3 8946 7510  email noorjahan@upm.edu.m yAbstract:  Anthraquinones are an important class of naturally occurring biologically active  compounds.",Non-OADS,/arxiv_data1/oa_pdf/c0/40/dddt-9-983.PMC4338775.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c0/40/dddt-9-983.PMC4338775.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/40/dddt-9-983.PMC4338775.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a9/f6/dddt-9-923.PMC4338776.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 923–935Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  923ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7354 4Effects of combined dietary supplementation with  fenofibrate and Schisandrae Fructus pulp on lipid  and glucose levels and liver function in normal  and hypercholesterolemic mice Pei-Li Zhu1  Si-Yuan Pan1  Shu-Feng Zhou2  Yi Zhang1  Xiao-Yan Wang1  Nan Sun1  Zhu-Sheng Chu1  Zhi-Ling Yu3  Kam-Ming Ko4 1Department of Pharmacology, School  of Chinese Materia Medica, Beijing  University of Chinese Medicine,  Beijing, People’s Republic of China;  2Department of Pharmaceutical  Sciences, College of Pharmacy,  University of South Florida, Tampa,  FL, USA; 3School of Chinese Medicine,  Hong Kong Baptist University,  Hong  Kong, People’s Republic of China;  4Division of Life Science, Hong Kong  University of Science and T echnology,  Hong Kong, People’s Republic of ChinaBackground:  Currently, combined therapy using herbs and synthetic drugs has become a  feasible therapeutic intervention against some diseases.",Non-OADS,/arxiv_data1/oa_pdf/a9/f6/dddt-9-923.PMC4338776.pdf
"Keywords:  bicyclol, hepatotoxicity, synergist, fatty liver disease, fat index, interaction Introduction Currently, combination therapy with herbal medicine and chemical drugs has become  popular all over the world,1–3 especially in the management of noncommunicable  diseases, which are the main causes of poor health, disability, and account for nearly  two-thirds of deaths worldwide.4 It is undisputed that lipid disorders and related  disease/complications, such as nonalcoholic fatty liver disease, obesity, metabolic Correspondence: Si-Yuan Pan Department of Pharmacology, School  of Chinese Materia Medica, Beijing  University of Chinese Medicine, 6  Wangjing Zhonghuan South Road, Chao  Yang District, Beijing 100102, People’s  Republic of China Tel +86 10 8473 8626 Fax +86 10 6472 1242 Email siyuan-pan@163.co m   Zhi-Ling Yu School of Chinese Medicine, Hong Kong  Baptist University, 7 Baptist University  Road, Kowloon Tong, Hong Kong,  People’s Republic of China Tel +852 3411 2465 Fax +852 3411 2461 Email zlyu@hkbu.edu.h k Journal name: Drug Design, Development and Therapy Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 9 Running head verso: Zhu et al Running head recto: Fenofibrate combined with Schisandrae Fructus and lipids DOI: http://dx.doi.org/10.2147/DDDT.S73544",Non-OADS,/arxiv_data1/oa_pdf/a9/f6/dddt-9-923.PMC4338776.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/a9/f6/dddt-9-923.PMC4338776.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a9/f6/dddt-9-923.PMC4338776.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/15/db/dddt-9-911.PMC4338777.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 911–921Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  911Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7389 0Design, synthesis, and computational studies   on dihydropyrimidine scaffolds as potential  lipoxygenase inhibitors and cancer  chemopreventive agents Katharigatta n Venugopala1,2 reshme govender2 Mohammed a Khedr1,3 rashmi Venugopala4 Bandar e aldhubiab1 sree harsha1 Bharti Odhav2 1Department of Pharmaceutical  sciences, college of clinical  Pharmacy, King Faisal University,   al-ahsa, Kingdom of saudi arabia;   2Department of Biotechnology and  Food T echnology, Durban University  of T echnology, Durban, south africa;   3Department of Pharmaceutical  chemistry, Faculty of Pharmacy,   helwan University, ein helwan, cairo,   egypt; 4Department of Public health  Medicine, University of KwaZulu- natal, howard college campus,   Durban, south africaAbstract:  Dihydropyrimidine scaffold has a wide range of potential pharmacological activi - ties such as antiviral, antitubercular, antimalarial, anti-inflammatory, and anticancer properties.",Non-OADS,/arxiv_data1/oa_pdf/15/db/dddt-9-911.PMC4338777.pdf
"Molecular docking is the correspondence: Katharigatta n  Venugopala Department of Pharmaceutical sciences,  college of clinical Pharmacy, King Faisal  University, PO Box number 400, al-ahsa  31982, Kingdom of saudi arabia Tel +966 13 589 8842 Fax +966 13 581 7174 email kvenugopala@kfu.edu.s a  Bharti Odhav Department of Biotechnology  and Food Technology, Durban University  of Technology, steve Biko campus,  s9, l1, Durban 4001, south africa Tel +27 31 373 5330 Fax +27 31 373 5351 email odahvb@dut.ac.z a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Venugopala et al Running head recto: DHPMs as potential lipoxygenase inhibitors and chemopreventive agents DOI: http://dx.doi.org/10.2147/DDDT.S73890",Non-OADS,/arxiv_data1/oa_pdf/15/db/dddt-9-911.PMC4338777.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/15/db/dddt-9-911.PMC4338777.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/15/db/dddt-9-911.PMC4338777.pdf
Available from: http://www.biosolveit.de / 25.,Non-OADS,/arxiv_data1/oa_pdf/15/db/dddt-9-911.PMC4338777.pdf
Available from: http://www.macrophages.com/ isolation-peripheral-blood-mononuclear-cells-pbmcs-whole-blood- and-subsequent-culture-macrophage-cel.,Non-OADS,/arxiv_data1/oa_pdf/15/db/dddt-9-911.PMC4338777.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/dddt-9-977.PMC4338778.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 977–981Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  977Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7823 31-1-12 one-step wash-in scheme for desflurane  low flow anesthesia: performance without  nitrous oxide Thepakorn sathitkarnmanee sirirat Tribuddharat Duangthida nonlhaopol Maneerat Thananun Wilawan somdee Department of anesthesiology, Faculty  of Medicine, Khon Kaen University,   Khon Kaen, ThailandBackground:  We reported a 1-1-12 wash-in scheme for desflurane-nitrous oxide (N2O) low  flow anesthesia that is simple, rapid, and predictable.",Non-OADS,/arxiv_data1/oa_pdf/5e/37/dddt-9-977.PMC4338778.pdf
"Recently, the authors reported  a simple, single step 1-1-12 wash-in scheme using an FGF of N2O:O2 1:1 L/min and  desflurane 12%, that can rapidly yield every FAD from 1% to 6% within 4 minutes  without tachycardia.7 Although N2O is widely used because of its desirable effects (eg,  analgesia and additive effect to the minimum alveolar concentration [MAC] of desflu - rane), there are still some situations where N2O should not be used,8–11 which effectively correspondence: sirirat Tribuddharat Department of anesthesiology, Faculty  of Medicine, Khon Kaen University,  123 Mitrapap road, ampur Maung,  Khon Kaen, 40002, Thailand Tel +66 81 954 7622 Fax +66 4334 8390 email sirirat.tribuddharat@gmail.com Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Sathitkarnmanee et al Running head recto: 1-1-12 wash-in scheme without nitrous oxide DOI: http://dx.doi.org/10.2147/DDDT.S78233",Non-OADS,/arxiv_data1/oa_pdf/5e/37/dddt-9-977.PMC4338778.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/5e/37/dddt-9-977.PMC4338778.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/37/dddt-9-977.PMC4338778.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/e7/dddt-9-969.PMC4338779.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 969–976Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  969Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7711 6human mesenchymal stem cells as delivery  of osteoprotegerin gene: homing and therapeutic  effect for osteosarcoma Bo Qiao Wei shui li cai shuquan guo Dianming Jiang Department of Orthopaedics,   The First affiliated hospital of  chongqing Medical University,   chongqing, People’s republic of china  Abstract:  Biological treatments have been studied extensively and previous studies have  proved that osteoprotegerin (OPG) can inhibit the development and progress of human osteo - sarcoma.",Non-OADS,/arxiv_data1/oa_pdf/b5/e7/dddt-9-969.PMC4338779.pdf
"1 Youyi road, Yuzhong  District, chongqing 400016, People’s  republic of china Tel +86 23 8901 1202 Fax +86 23 8901 1217 email 514629902@qq.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Qiao et al Running head recto: MSCs delivering OPG gene to treat osteosarcoma DOI: http://dx.doi.org/10.2147/DDDT.S77116",Non-OADS,/arxiv_data1/oa_pdf/b5/e7/dddt-9-969.PMC4338779.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/b5/e7/dddt-9-969.PMC4338779.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/e7/dddt-9-969.PMC4338779.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/72/dddt-9-937.PMC4338781.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 937–968Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  937Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7602 1Proteomic response to 5,6-dimethylxanthenone  4-acetic acid (DMXaa, vadimezan) in human non- small cell lung cancer a549 cells determined by  the stable-isotope labeling by amino acids in cell  culture (silac) approach  correspondence: shu-Feng Zhou Department of Pharmaceutical sciences,  college of Pharmacy, University of south  Florida, 12901 Bruce B. Downs Boulevard,  Tampa, Fl 33612, Usa  Tel +1 813 974 6276 Fax +1 813 905 9885 email szhou@health.usf.ed u Jia-Xuan Qiu Department of Oral and Maxillofacial surgery,  The First Affiliated Hospital of Nanchang  University, 17 Yongwaizheng st, nanchang  330006, Jiangxi, People’s republic of china Tel +86 791 8869 5069 Fax +86 791 8869 2745 email qiujiaxuan@163.co mshu-Ting Pan,1,* Zhi-Wei Zhou,2,3,*  Zhi-Xu he,3 Xueji Zhang,4 Tianxin  Yang,5 Yin-Xue Yang,6 Dong Wang,7  Jia-Xuan Qiu,1 shu-Feng Zhou2 1Department of Oral and Maxillofacial  surgery, The First affiliated hospital of  nanchang University, nanchang, Jiangxi,   People’s republic of china; 2Department  of Pharmaceutical sciences, college of  Pharmacy, University of south Florida,   Tampa, Fl, Usa; 3guizhou Provincial Key  laboratory for regenerative Medicine,   stem cell and Tissue engineering research  center and sino-U s Joint laboratory  for Medical sciences, guiyang Medical  University, guiyang, 4research center  for Bioengineering and sensing T echnology,   University of science and Technology  Beijing, Beijing, People’s republic of  china; 5Department of internal Medicine,   University of Utah and salt lake Veterans  affairs Medical center, salt lake city, UT,   Usa; 6Department of colorectal surgery,   general hospital of ningxia Medical  University, Yinchuan, 7cancer center,   Daping hospital and research institute  of surgery, Third Military Medical University,   chongqing, People’s republic of china *These two authors contributed equally  to this workAbstract:  5,6-Dimethylxanthenone 4-acetic acid (DMXAA), also known as ASA404 and  vadimezan, is a potent tumor blood vessel-disrupting agent and cytokine inducer used alone or in  combination with other cytotoxic agents for the treatment of non-small cell lung cancer (NSCLC)  and other cancers.",Non-OADS,/arxiv_data1/oa_pdf/ea/72/dddt-9-937.PMC4338781.pdf
"In the USA, there were 207,339 new cases of lung cancer and 156,953 deaths resulting Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Pan et al Running head recto: Proteomic response to DMXAA in A549 cells DOI: http://dx.doi.org/10.2147/DDDT.S76021",Non-OADS,/arxiv_data1/oa_pdf/ea/72/dddt-9-937.PMC4338781.pdf
"Available from: http://globocan.iarc.f r. Accessed December 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ea/72/dddt-9-937.PMC4338781.pdf
"Available from:  http://www.cdc.gov/cancer/npcr/pdf/USCS_FactSheet.pd f. Accessed  December 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ea/72/dddt-9-937.PMC4338781.pdf
Available from: http://www.can - cer.org/research/cancerfactsstatistics/cancerfactsfigures2014 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/72/dddt-9-937.PMC4338781.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ea/72/dddt-9-937.PMC4338781.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/72/dddt-9-937.PMC4338781.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/59/dddt-9-993.PMC4338783.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 993–1026Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  993Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7349 3Bardoxolone methyl induces apoptosis and  autophagy and inhibits epithelial-to-mesenchymal  transition and stemness in esophageal squamous   cancer cells Yan-Yang Wang,1,2 Yin-Xue  Yang,3 ren Zhao,1 shu-Ting  Pan,2,4 hong Zhe,1 Zhi-Xu  he,5 Wei Duan,6 Xueji Zhang,7  Tianxin Yang,8 Jia-Xuan Qiu,4  shu-Feng Zhou2,5 1Department of radiation Oncology, general  hospital of ningxia Medical University,  Yinchuan, People’s republic of china;  2Department of Pharmaceutical sciences,  college of Pharmacy, University of south  Florida, Tampa, Fl, Usa; 3Department  of colorectal surgery, general hospital  of ningxia Medical University, Yinchuan,  People’s republic of china; 4Department  of Oral and Maxillofacial surgery, The  First affiliated hospital of nanchang  University, nanchang, 5guizhou Provincial  Key laboratory for regenerative Medicine,  stem cell and Tissue engineering research  center and sino-U s Joint laboratory for  Medical sciences, guiyang Medical University,  guiyang, People’s republic of china; 6school  of Medicine, Deakin University, Waurn  Ponds, Vic , australia; 7research center  for Bioengineering and sensing T echnology,  University of science and T echnology  Beijing, Beijing, People’s republic of china;  8Department of internal Medicine, University  of Utah and salt lake Veterans affairs  Medical center, salt lake city, UT, UsaAbstract:  Natural and synthetic triterpenoids have been shown to kill cancer cells via multiple mech - anisms.",Non-OADS,/arxiv_data1/oa_pdf/93/59/dddt-9-993.PMC4338783.pdf
"Down Boulevard,  Tampa, Fl 33612, Usa Tel +1 813 974 6276 Fax +1 813 905 9885 email szhou@health.usf.ed u Jia-Xuan Qiu Department of Oral and Maxillofacial surgery,  The First Affiliated Hospital of Nanchang  University, 17 Yongwaizheng st, nanchang  330006, Jiangxi, People’s republic of china Tel +86 791 8869 2531 Fax +86 791 8869 2745 email qiujiaxuan@163.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wang et al Running head recto: The anticancer mechanism of CDDO-Me in esophageal cancer DOI: http://dx.doi.org/10.2147/DDDT.S73493",Non-OADS,/arxiv_data1/oa_pdf/93/59/dddt-9-993.PMC4338783.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/93/59/dddt-9-993.PMC4338783.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/93/59/dddt-9-993.PMC4338783.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/64/dddt-9-1027.PMC4338784.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1027–1062Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1027Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7441 2The pan-inhibitor of aurora kinases danusertib  induces apoptosis and autophagy and suppresses  epithelial-to-mesenchymal transition in human  breast cancer cells Jin-Ping li,1,2 Yin-Xue Yang,3  Qi-lun liu,1 Zhi-Wei Zhou,2,4  shu-Ting Pan,2,5 Zhi-Xu he,4   Xueji Zhang,6 Tianxin Yang,7  si-Yuan Pan,8 Wei Duan,9   shu-Ming he,10 Xiao-Wu chen,11  Jia-Xuan Qiu,5 shu-Feng Zhou2,4 1Department of surgical Oncology, general  hospital of n ingxia Medical University, Yinchuan,  ningxia, People’s republic of china; 2Department  of Pharmaceutical sciences, college of Pharmacy,  University of south Florida, Tampa, Fl, Usa;  3Department of colorectal surgery, general  hospital of n ingxia Medical University, Yinchuan,  ningxia, People’s republic of china; 4guizhou  Provincial Key laboratory for regenerative  Medicine, stem cell and Tissue engineering  research center and sino-Us Joint laboratory  for Medical sciences, guiyang Medical University,  guiyang, guizhou, People’s republic of china;  5Department of Oral and Maxillofacial surgery,  The First affiliated hospital of nanchang University,  nanchang, Jiangxi, People’s republic of china;  6research center for Bioengineering and sensing  Technology, University of science and Technology  Beijing, Beijing, People’s republic of china;  7Department of internal Medicine, University  of Utah and salt lake Veterans affairs Medical  center, salt lake city, UT, Usa; 8Department of  Pharmacology, school of chinese Materia Medica,  Beijing University of chinese Medicine, Beijing,  People’s republic of china; 9school of Medicine,  Deakin University, Waurn Ponds, Vic , australia;  10Department of Obstetrics and gynecology,  Xiaolan People’s hospital affiliated to southern  Medical University, Zhongshan, guangdong, People’s  republic of china; 11Department of general  surgery, The First People’s hospital of shunde  affiliated to southern Medical University, shunde,  Foshan, guangdong, People’s republic of china Abstract:  Danusertib (Danu) is a pan-inhibitor of Aurora kinases and a third-generation breakpoint  cluster region-Abelson murine leukemia viral oncogene homolog 1 (Bcr-Abl) tyrosine kinase  inhibitor, but its antitumor effect and underlying mechanisms in the treatment of human breast  cancer remain elusive.",Non-OADS,/arxiv_data1/oa_pdf/0c/64/dddt-9-1027.PMC4338784.pdf
"Keywords:  Danusertib, breast cancer, cell cycle, apoptosis, autophagy, EMT Introduction Breast cancer is a major health issue worldwide and has been considered as the second  most common cancer and the most common cause of cancer-related death in women correspondence: shu-Feng Zhou Department of Pharmaceutical sciences, college of  Pharmacy, University of south Florida, 12901 Bruce B.  Downs Blvd., MDc 30, Tampa, Fl 33612, Usa Tel +1 813 974 6276  Fax +1 813 905 9885 email szhou@health.usf.ed u Jia-Xuan Qiu Department of Oral and Maxillofacial surgery,   The First Affiliated Hospital of Nanchang University,   17 Yongwaizheng st, nanchang 330006, Jiangxi,   People’s republic of china Tel +86 791 8869 2531 Fax +86 791 8869 2745 email qiujiaxuan@163.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Li et al Running head recto: Danusertib kills breast cancer cells DOI: http://dx.doi.org/10.2147/DDDT.S74412",Non-OADS,/arxiv_data1/oa_pdf/0c/64/dddt-9-1027.PMC4338784.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0c/64/dddt-9-1027.PMC4338784.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/64/dddt-9-1027.PMC4338784.pdf
"Genes in these libraries (http://www.bcmgeneticlabs.org) were selected on the basis of their  structurally or functionally interactive relationship, involve- ment in the same or related pathways, or phenotypic simi-larities ( Supplementary Table S1 online).",OADS,/arxiv_data1/oa_pdf/bc/33/gim201480a.PMC4338802.pdf
The script for  the detection of CNVs is deposited at https://sourceforge.net/ projects/cnvanalysis.,OADS,/arxiv_data1/oa_pdf/bc/33/gim201480a.PMC4338802.pdf
SUPPLEMENTARY MATERIAL Supplementary material is linked to the online version of the paper  at http://www.nature.com/gim  Volume 17  |  Number 2  |  February 2015  |  Genetics in Medicine,Non-OADS,/arxiv_data1/oa_pdf/bc/33/gim201480a.PMC4338802.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/  Genetics in Medicine  |   Volume 17  |  Number 2  |  February 2015",Non-OADS,/arxiv_data1/oa_pdf/bc/33/gim201480a.PMC4338802.pdf
"Image stacks werealigned using a custom-made plugin, Stackreg ( http://bigwww.epﬂ.ch/ thevenaz/stackreg/ ).",OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
FRET/YFP ratios were calculated using Ratio Plus (http://rsbweb.nih.gov/ij/plugins/ratio-plus.html ).,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
"115337), a joint undertaking of the EuropeanUnion Seventh Framework Programme and EFPIA ( http://www.imi.eu- ropa.eu /).",Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1038/nrd3975 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1038/nrd2201 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1038/nrd3289 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/ 10.1126/science.1106753 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1016/S1473 -3099(13)70328-1 .,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1016/ j.cell.2014.02.050 .,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1007/82_2013_333 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1016/ j.chom.2014.11.016 .,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1021/cr100002u .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
BMC Biol 10:28. http://dx.doi.org/ 10.1186/1741-7007-10-28 .,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
Biotechnol Biofuels1:11. http://dx.doi.org/10.1186/1754-6834-1-11 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
Sci Rep 4:6522. http://dx.doi.org/10.1038/srep06522 .,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1038/nm.3262 .,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1074/jbc.275.6.3931 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1074/jbc.M803899200 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1099/ mic.0.033084-0 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1074/ jbc.M311996200 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/ 10.1073/pnas.0904764106 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1371/journal.ppat.1002561 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1128/AAC.00507-11 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1126/science.1229858 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.3791/3410 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1128/ JB.184.9.2420-2428.2002 .,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1126/science.1171583 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1021/cb2004884 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/ 10.1016/j.cell.2012.02.015 .,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1038/nrmicro3076 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/10.1128/AAC.00243-13 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
Front Microbiol 5:70.http://dx.doi.org/10.3389/ fmicb.2014.00070 .,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/ 10.1007/s002030100290 .,Non-OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
BMCBioinformatics 15:251. http://dx.doi.org/10.1186/1471-2105-15-251 .,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
http://dx.doi.org/ 10.1093/jac/48.suppl_1.5 .ATP Tracking in Single Cells January/February 2015 Volume 6 Issue 1 e02236-14®mbio.asm.org 11,OADS,/arxiv_data1/oa_pdf/95/16/mBio.02236-14.PMC4338811.pdf
"Autophagy incancer Xiaoyong Zhi1andQing Zhong2* Addresses:1Center forAutophagy Research, Department ofInternal Medicine, University ofTexas Southwestern Medical Center, Dallas, Texas 75390, USA;2Department ofBiochemistry, University ofTexas Southwestern Medical Center, Dallas, Texas 75390, USA *Corresponding author: Qing Zhong (Qing.Zhong@UTSouthwestern.edu) F1000Prime Reports 2015, 7:18(doi:10.12703/P7-18) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/7/18 Abstract Autophagy isacatabolic degradation process inwhich cellular proteins andorganelles areengulfed by double-membrane autophagosomes anddegraded inlysosomes.,Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
"Page 2 of 12 (page number not for citation purposes)F1000Prime Reports 2015, 7:18 http://f1000.com/prime/reports/b/7/18",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
"In a recent study, White ’s group utilized a novel strategy to dissect the function of autophagy in tumorigenesis Page 3 of 12 (page number not for citation purposes)F1000Prime Reports 2015, 7:18 http://f1000.com/prime/reports/b/7/18",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
"Page 4 of 12 (page number not for citation purposes)F1000Prime Reports 2015, 7:18 http://f1000.com/prime/reports/b/7/18",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
"The rationale is that chemother- apy and immunotherapy can induce autophagy in tumor Page 5 of 12 (page number not for citation purposes)F1000Prime Reports 2015, 7:18 http://f1000.com/prime/reports/b/7/18",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
"Page 6 of 12 (page number not for citation purposes)F1000Prime Reports 2015, 7:18 http://f1000.com/prime/reports/b/7/18",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
"Page 7 of 12 (page number not for citation purposes)F1000Prime Reports 2015, 7:18 http://f1000.com/prime/reports/b/7/18",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
"Page 8 of 12 (page number not for citation purposes)F1000Prime Reports 2015, 7:18 http://f1000.com/prime/reports/b/7/18",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
"Rangwala R, Leone R, Chang YC, Fecher LA, Schuchter LM, Kramer A, Tan K, Heitjan DF, Rodgers G, Gallagher M, Piao S, Troxel AB,Evans TL, DeMichele AM, Nathanson KL, O ’Dwyer PJ, Kaiser J, Pontiggia L, Davis LE, Amaravadi RK: Phase I trial of hydroxy- chloroquine with dose-intense temozolomide in patients Page 9 of 12 (page number not for citation purposes)F1000Prime Reports 2015, 7:18 http://f1000.com/prime/reports/b/7/18",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
":Selective VPS34 inhibitor blocks autophagy Page 10 of 12 (page number not for citation purposes)F1000Prime Reports 2015, 7:18 http://f1000.com/prime/reports/b/7/18",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
"Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, Thomas-Tikhonenko A, Thompson CB: Autophagy inhibition Page 11 of 12 (page number not for citation purposes)F1000Prime Reports 2015, 7:18 http://f1000.com/prime/reports/b/7/18",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
"Page 12 of 12 (page number not for citation purposes)F1000Prime Reports 2015, 7:18 http://f1000.com/prime/reports/b/7/18",Non-OADS,/arxiv_data1/oa_pdf/e5/ac/biolrep-07-18.PMC4338832.pdf
"Structure andmechanism ofABC transporters Stephan Wilkens Address: Department ofBiochemistry, State University ofNew York Upstate Medical University, Syracuse, NY13210, USA Email: wilkenss@upstate.edu F1000Prime Reports 2015, 7:14(doi:10.12703/P7-14) AllF1000Prime Reports articles aredistributed under theterms oftheCreative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits non-commercial use, distribution, andreproduction inanymedium, provided theoriginal work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/biolrep-07-14.PMC4338842.pdf
The electronic version ofthisarticle isthecomplete oneandcanbefound at:http://f1000.com/prime/reports/b/7/14 Abstract Allliving organisms depend onprimary andsecondary membrane transport forthesupply ofexternal nutrients andremoval orsequestration ofunwanted (toxic) compounds.,Non-OADS,/arxiv_data1/oa_pdf/b0/8c/biolrep-07-14.PMC4338842.pdf
"Properties of the TMDs Depending on the transporter class, each TMD has 6 to 10 transmembrane a-helices (with most exporters having 6) Page 2 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:14 http://f1000.com/prime/reports/b/7/14",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/biolrep-07-14.PMC4338842.pdf
"Page 3of9 (page number notforcitation purposes)F1000Prime Reports 2015, 7:14 http://f1000.com/prime/reports/b/7/14",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/biolrep-07-14.PMC4338842.pdf
"According to the switch model[33], which was inspired by biochemical studies andearly crystal structures that showed (on the one hand)ATP-dependent dimerization of isolated NBDs [20] and(on the other hand) intact apo (ATP and substrate-free)transporters in which the NBDs were seen far apart[26,27,43] (see Figure 1D and C, respectively), the NBDs have to dissociate completely for product release and the Page 4 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:14 http://f1000.com/prime/reports/b/7/14",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/biolrep-07-14.PMC4338842.pdf
"Page 5of9 (page number notforcitation purposes)F1000Prime Reports 2015, 7:14 http://f1000.com/prime/reports/b/7/14",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/biolrep-07-14.PMC4338842.pdf
"Page 6 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:14 http://f1000.com/prime/reports/b/7/14",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/biolrep-07-14.PMC4338842.pdf
"Smith PC, Karpowich N, Millen L, Moody JE, Rosen J, Thomas PJ, Hunt JF: ATP binding to the motor domain from an ABC Page 7 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:14 http://f1000.com/prime/reports/b/7/14",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/biolrep-07-14.PMC4338842.pdf
"Page 8 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:14 http://f1000.com/prime/reports/b/7/14",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/biolrep-07-14.PMC4338842.pdf
"Page 9 of 9 (page number not for citation purposes)F1000Prime Reports 2015, 7:14 http://f1000.com/prime/reports/b/7/14",Non-OADS,/arxiv_data1/oa_pdf/b0/8c/biolrep-07-14.PMC4338842.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/f0/main.PMC4338853.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.11.001 2213-3232/© 2014 Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/80/f0/main.PMC4338853.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/80/f0/main.PMC4338853.pdf
J Mol Neurosci 2014. http://dx.doi.org/10.1007/s12031-014-0377-5 .,Non-OADS,/arxiv_data1/oa_pdf/80/f0/main.PMC4338853.pdf
Prog Neuropsychopharmacol Biol Psy- chiatry Sep 18 2014;56C:161 –7.http://dx.doi.org/10.1016/j.pnpbp.2014.09.001 .,OADS,/arxiv_data1/oa_pdf/80/f0/main.PMC4338853.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/79/main.PMC4338854.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.10.003 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/44/79/main.PMC4338854.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/44/79/main.PMC4338854.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/41/main.PMC4338855.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.07.003 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/41/main.PMC4338855.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/41/main.PMC4338855.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/54/main.PMC4338856.pdf
Contents lists available at ScienceDirect Epilepsy & Behavior Case Reports journal homepage: www.elsevier.com/locate/ebcr http://dx.doi.org/10.1016/j.ebcr.2014.11.002 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/bb/54/main.PMC4338856.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bb/54/main.PMC4338856.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/15/main.PMC4338858.pdf
http://dx.doi.org/10.1016/j.ebcr.2014.10.002 2213-3232/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/15/main.PMC4338858.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ec/15/main.PMC4338858.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/61/main.PMC4338950.pdf
"Direct link to deposited data All data are available through ENCODE data portals: https://www.encodeproject.org http://www.mouseencode.org The GATA1-ChIP-seq data sets are available in three GEO Series: GSE51338, GSE36029, and GSE49847.",OADS,/arxiv_data1/oa_pdf/51/61/main.PMC4338950.pdf
"http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51338 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE36029 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49847 The RNA-seq data sets are available in three GEO Series: GSE40522, GSE51338, and GSE49847.",OADS,/arxiv_data1/oa_pdf/51/61/main.PMC4338950.pdf
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40522 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE51338 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE49847 The individual data sets and links are listed in Table 1 .,OADS,/arxiv_data1/oa_pdf/51/61/main.PMC4338950.pdf
Consent Not applicableSample source locationNot applicable http://dx.doi.org/10.1016/j.gdata.2015.01.008 2213-5960/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/51/61/main.PMC4338950.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/51/61/main.PMC4338950.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/51/61/main.PMC4338950.pdf
Cell Treatment with estradiol Feature Replicates ⁎ GEO accession URL G1E Untreated Paired-end RNA-seq 2 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995536 G1E-ER4 Untreated Paired-end RNA-seq 2 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995532 G1E-ER4 3 h Paired-end RNA-seq 2 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995538 G1E-ER4 7 h Paired-end RNA-seq 2 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995531 G1E-ER4 14 h Paired-end RNA-seq 2 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995527 G1E-ER4 24 h Paired-end RNA-seq 2 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995539 G1E-ER4 30 h Paired-end RNA-seq 2 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995541 G1E Untreated GATA1 ChIP-seq 2 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM923581 G1E-ER4 Untreated GATA1 ChIP-seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995445 G1E-ER4 3 h GATA1 ChIP-seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995443 G1E-ER4 7 h GATA1 ChIP-seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995442 G1E-ER4 14 h GATA1 ChIP-seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995444 G1E-ER4 24 h GATA1 ChIP-seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM923572 G1E-ER4 30 h GATA1 ChIP-seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995448 G1E Untreated Input seq 2 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM923580 G1E-ER4 Untreated Input seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995441 G1E-ER4 3 h Input seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995437 G1E-ER4 7 h Input seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995436 G1E-ER4 14 h Input seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995440 G1E-ER4 24 h Input seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995439 G1E-ER4 30 h Input seq 1 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSM995438 ⁎Number.2 D. Jain et al.,Non-OADS,/arxiv_data1/oa_pdf/51/61/main.PMC4338950.pdf
The results are available from ( https://docs.google.com/ spreadsheet/ccc?key=0Ao3-Or4FCMJEdFpPY2lwWnlZTV92MUNLOHYxbEl4Vnc&usp=drive_web#gid=0 ).,OADS,/arxiv_data1/oa_pdf/51/61/main.PMC4338950.pdf
"7,21In brief, normalized gray and white matter vol- umes and lesion volumes were quantiﬁed automatically using k nearest neighbor classiﬁcation with tissue typepriors (KNN-TTP), and SIENAX (part of the FMRIBSoftware Library [FSL] 5.0.4, http://www.fmrib.ox.ac.uk/fsl).",OADS,/arxiv_data1/oa_pdf/5f/ee/acn30002-0140.PMC4338955.pdf
Project http://www.nitrc.org/projects/fcon_1000/.7The areas identiﬁed in this study encompass a broad languagenetwork including phonological and lexical-semanticfunctions.,Non-OADS,/arxiv_data1/oa_pdf/f0/24/acn30002-0185.PMC4338958.pdf
"R package version 1.1 –7, http://CRAN.R-project.org/package=lme4 ª2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/3f/90/acn30002-0208.PMC4338961.pdf
2014 http://www.jointcommission.org/ assets/1/6/HAP_NPSG_Chapter_2014.pdf .,OADS,/arxiv_data1/oa_pdf/de/ba/nihms660845.PMC4339072.pdf
"Available from: http://www.ncbi.nlm.nih.gov/books/NBK20494/  [Accessed October 5, 2014]Barajas et al.",Non-OADS,/arxiv_data1/oa_pdf/de/ba/nihms660845.PMC4339072.pdf
http://www.plainlanguage.gov/howto/quickreference/checklist.cfm 25.,Non-OADS,/arxiv_data1/oa_pdf/de/ba/nihms660845.PMC4339072.pdf
The protein motif algorithm ScanSite (http://scansite.mit.edu/) predicted a potential phosphorylation site on HSF1 atserine 121 residue (Supplementary Fig S3A).,OADS,/arxiv_data1/oa_pdf/72/e8/embj0034-0275.PMC4339117.pdf
Statistical significance: * P<0.05; ** P<0.01; *** P<0.001.Supplementary information for this article is available online: http://emboj.embopress.org Acknowledgements We would like to thank Dr. Ivor Benjamin for Hsf1MEFs and mice; Dr. Luke Whitesell for cell lines; Barbara Tennent for critically reading the manuscript;and Xin Wang and Xiongtao Ruan for their technical assistance.,Non-OADS,/arxiv_data1/oa_pdf/72/e8/embj0034-0275.PMC4339117.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/42/2e/jpts-27-315.PMC4339128.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/16/e9/jpts-27-317.PMC4339129.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9b/5c/jpts-27-321.PMC4339130.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ac/21/jpts-27-325.PMC4339131.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a8/eb/jpts-27-331.PMC4339132.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/16/6a/jpts-27-341.PMC4339133.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/77/28/jpts-27-345.PMC4339134.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/03/a1/jpts-27-349.PMC4339135.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f5/40/jpts-27-353.PMC4339136.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/c9/12/jpts-27-357.PMC4339137.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/96/47/jpts-27-361.PMC4339138.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/84/c1/jpts-27-367.PMC4339139.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/b2/47/jpts-27-371.PMC4339140.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ec/5a/jpts-27-375.PMC4339141.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d9/b3/jpts-27-377.PMC4339142.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/5a/cf/jpts-27-383.PMC4339143.pdf
[Medline]   [CrossRef] 14) Surface Electromyography for Non-Invasive Assessment of Muscles: http://www.seniam.org.,Non-OADS,/arxiv_data1/oa_pdf/5a/cf/jpts-27-383.PMC4339143.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/66/4b/jpts-27-387.PMC4339144.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a0/9b/jpts-27-389.PMC4339145.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f3/46/jpts-27-393.PMC4339146.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/77/43/jpts-27-397.PMC4339147.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/1d/74/jpts-27-401.PMC4339148.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/94/73/jpts-27-405.PMC4339149.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/7c/62/jpts-27-411.PMC4339150.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f0/0d/jpts-27-415.PMC4339151.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/46/02/jpts-27-421.PMC4339152.pdf
http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/46/02/jpts-27-421.PMC4339152.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/2f/b9/jpts-27-427.PMC4339153.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a1/61/jpts-27-433.PMC4339154.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/e5/66/jpts-27-437.PMC4339155.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9e/da/jpts-27-441.PMC4339156.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/63/ee/jpts-27-447.PMC4339157.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/25/86/jpts-27-451.PMC4339158.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/10/b4/jpts-27-455.PMC4339159.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/e3/d1/jpts-27-457.PMC4339160.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/7e/7b/jpts-27-461.PMC4339161.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/jpts-27-465.PMC4339162.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/0f/16/jpts-27-469.PMC4339163.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0e/c8/jpts-27-473.PMC4339164.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/f0/ed/jpts-27-477.PMC4339165.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/5e/5a/jpts-27-481.PMC4339166.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/85/fb/jpts-27-485.PMC4339167.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/78/13/jpts-27-489.PMC4339168.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/bf/ba/jpts-27-491.PMC4339169.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/55/32/jpts-27-495.PMC4339170.pdf
[homepage on the Internet] c2012 http://sites.duke.edu/ atdesign/2012/10/11/computer-games-for-learning-joystick-control/ (Ac - cessed Mar.,Non-OADS,/arxiv_data1/oa_pdf/55/32/jpts-27-495.PMC4339170.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/45/2d/jpts-27-499.PMC4339171.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/0e/a7/jpts-27-501.PMC4339172.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/ff/24/jpts-27-505.PMC4339173.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/2c/c4/jpts-27-509.PMC4339174.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/af/b7/jpts-27-513.PMC4339175.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/a3/e5/jpts-27-517.PMC4339176.pdf
[Medline]   [CrossRef] 5) Ministry of Health: Labour and Welfare: Guideline of Health- enhancing Physical Activity in 2013. http://www.mhlw.go.jp/stf/ houdou/2r9852000002xple.html.,Non-OADS,/arxiv_data1/oa_pdf/a3/e5/jpts-27-517.PMC4339176.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/1d/a1/jpts-27-523.PMC4339177.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/fd/61/jpts-27-527.PMC4339178.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/d2/b4/jpts-27-531.PMC4339179.pdf
This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Cre- ative	Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc- nd)	License	<http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original	Article,Non-OADS,/arxiv_data1/oa_pdf/6c/30/jpts-27-535.PMC4339180.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/3b/d2/jpts-27-539.PMC4339181.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Original Article,Non-OADS,/arxiv_data1/oa_pdf/9b/96/jpts-27-543.PMC4339182.pdf
This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Case Study,Non-OADS,/arxiv_data1/oa_pdf/0b/3b/jpts-27-547.PMC4339183.pdf
[Medline]   [Cross - Ref] 5) Jason Sweas: http://jasonsweas.wordpress.com/patient-education/shoul - der-scapula/.,Non-OADS,/arxiv_data1/oa_pdf/0b/3b/jpts-27-547.PMC4339183.pdf
"Received:  March 20, 2014; Revised:  July 2, 2014; Accepted:  November 25, 2014JNCI J Natl Cancer Inst (2015) 107(2): dju423 doi:10.1093/jnci/dju423 First published online January, 7, 2015 Article 1 of 7 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9a/5e/dju423.PMC4339260.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/a5/main.PMC4339529.pdf
6Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/cuthreCurrent Therapeutic Research http://dx.doi.org/10.1016/j.curtheres.2015.01.002 0011-393X/ &2015.,OADS,/arxiv_data1/oa_pdf/fc/a5/main.PMC4339529.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fc/a5/main.PMC4339529.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/34/gfu297.PMC4339685.pdf
SUPPLEMENTARY DATA Supplementary data are available online at http://ndt.oxford journals.org.,OADS,/arxiv_data1/oa_pdf/2d/34/gfu297.PMC4339685.pdf
"November 2012. http://www.medicines.org.uk/EMC/medicine/889/SPC/ Eprex+2000%2c+4000+and+10000+IU+ml+solution+for+injection+in+ pre-ﬁlled+syringe/ (14 February 2014, date last accessed) 10.",Non-OADS,/arxiv_data1/oa_pdf/2d/34/gfu297.PMC4339685.pdf
"Health Sciences Authority Dear Healthcare Professional Letters, October 2013 http://www.hsa.gov.sg/publish/hsapo rtal/en/health_products_regulation/ safety_information/DHCPL/2013.html , (14 February 2014, date last accessed) Received for publication: 2.4.2014; Accepted in revised form: 6.8.2014 Nephrol Dial Transplant (2015) 30: 460 –466 doi: 10.1093/ndt/gfu312 Advance Access publication 7 October 2014 Increased plasma dipeptidyl peptidase 4 activities predict new-onset microalbuminuria in association with itsproin ﬂammatory effects in Chinese without diabetes: a four-year prospective study Tianpeng Zheng1,2, Attit Baskota1, Yun Gao1, Haoming Tian1and Fan Yang2 1Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, Sichuan, P.R.",Non-OADS,/arxiv_data1/oa_pdf/2d/34/gfu297.PMC4339685.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution Non-Commercial License ( http://creativecommons.org/ licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.For commercial re-use, please contact journals.permissions@oup.com475",Non-OADS,/arxiv_data1/oa_pdf/f7/88/gfu329.PMC4339688.pdf
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ba/32/main.PMC4339700.pdf
Contents lists available at ScienceDirect Seminars in Fetal & Neonatal Medicine journal homepage: www.elsevier.com/locate/siny http://dx.doi.org/10.1016/j.siny.2014.08.007 1744-165X/ ©2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ba/32/main.PMC4339700.pdf
This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ ).Seminars in Fetal & Neonatal Medicine 19 (2014) 306 e311,Non-OADS,/arxiv_data1/oa_pdf/ba/32/main.PMC4339700.pdf
WHO reference number: WQ 450 98BA 1998 [available at: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/ba/32/main.PMC4339700.pdf
Dev Neurorehabil 2013 Nov 1. http://dx.doi.org/10.3109/17518423.20 13.847980 [Epub ahead of print].,Non-OADS,/arxiv_data1/oa_pdf/ba/32/main.PMC4339700.pdf
"Section A170.002 Prohibited Acts; exemption [available at: http://www.statutes.legis.state.tx.us/Docs/SDocs/HEALTHAND SAFETYCODE.pdf ], eff.",Non-OADS,/arxiv_data1/oa_pdf/ba/32/main.PMC4339700.pdf
Section 285.202 Use of tax revenue for abor- tions; exception for medical emergency [available at: http://www.weblaws.,Non-OADS,/arxiv_data1/oa_pdf/ba/32/main.PMC4339700.pdf
"accessed at:; 2007. on February 19, 2014 http://www.womenslinkworldwide.org/pdf_ pubs/pub_c3552006.pdf .",Non-OADS,/arxiv_data1/oa_pdf/ba/32/main.PMC4339700.pdf
"Supreme Court abortion ruling a positive step: expands exceptions to criminal penalties to include fatal disorder of fetus [available at: http://www.hrw.org/news/2012/04/19/brazil-supreme-court- abortion-ruling-positive-step ]; April 19, 2012.",Non-OADS,/arxiv_data1/oa_pdf/ba/32/main.PMC4339700.pdf
23 August 2014 available at http://seattletimes.com/html/localnews/ 2024377057_herrerabeutlerxml.html .D.,Non-OADS,/arxiv_data1/oa_pdf/ba/32/main.PMC4339700.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/bb/afu145.PMC4339726.pdf
"In addition, we examined other sources, such as recently published textbooks, theBritish National Formulary and NICE ( http://www.nice.",Non-OADS,/arxiv_data1/oa_pdf/ee/bb/afu145.PMC4339726.pdf
"org.uk/ )a n dS I G N( http://www.sign.ac.uk/guidelines/ published/numlist.html , 1 March 2014, date last accessed) treatment guidelines for sources of references.",Non-OADS,/arxiv_data1/oa_pdf/ee/bb/afu145.PMC4339726.pdf
"National Hip Fracture Database, 2011. http://www.nhfd.co.uk/ 003/hipfracturer.nsf/NHFDNationalReport2011_Final.pdf .",OADS,/arxiv_data1/oa_pdf/d5/fd/afu168.PMC4339727.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/fd/afu168.PMC4339727.pdf
"2007. http://www.communities.gov.uk/ communities/neighbourhoodrenewal/deprivation/deprivation07(November 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d5/fd/afu168.PMC4339727.pdf
"Quality and Outcomes Framework 2011-12. http://www.hscic.gov.uk/ catalogue/PUB08135 (October 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/d5/fd/afu168.PMC4339727.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/8c/afu187.PMC4339728.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/b4/afu189.PMC4339729.pdf
"Human ageing is inevitably associated with declining func- tion in later years; however, at all life stages, humans can move upward or downward on the vitality/apathy axis.Acknowledgements The authors acknowledge the contributions of speakers at Cultures of Health and Aging (http://healthyaging.ku.dk/news/ cultures_in_aging/ 19 November 2014 date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/3a/b4/afu189.PMC4339729.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 68 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/62/dyu027.PMC4339754.pdf
"15 Finally, the making of a study of this size and complex- ity in a middle-income country striving to give the priority needed to research of non-communicable diseases wasaddressed in detail (in English and Portuguese) in a recent supplement of the Revista de Sau ´de Pu ´blica which can be accessed through the link http://www.scielo.br/scielo.php?script¼sci_issuetoc&pid ¼0034-891020130008&lng ¼pt& nrm¼iso.",Non-OADS,/arxiv_data1/oa_pdf/51/62/dyu027.PMC4339754.pdf
"Available at: http://www.un.org/ga/search/view_doc.asp?symbol ¼A%2F 66%2FL.1&Lang ¼E (5 February 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/51/62/dyu027.PMC4339754.pdf
"VCThe Author 2014; Published by Oxford University Press on behalf of the International Epidemiological Association 229 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/7d/dyu182.PMC4339758.pdf
php?p¼data] and ELSA data are available from the UK data service [http://discover.ukdataservice.ac.uk/].Key Messages •Comparing the health of populations based on the prevalence of health conditions does not give the full story about health comparisons.,OADS,/arxiv_data1/oa_pdf/e4/7d/dyu182.PMC4339758.pdf
"http://www.elsa-project.ac.uk/ (19 August 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/e4/7d/dyu182.PMC4339758.pdf
"http://www.who.int/healthinfo/survey/ instruments/en/ (19 August 2014, date last accessed).",OADS,/arxiv_data1/oa_pdf/e4/7d/dyu182.PMC4339758.pdf
"238 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/ 4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.238 International Journal of Epidemiology , 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/e4/7d/dyu182.PMC4339758.pdf
"Published by Oxford University Press on behalf of the International Epidemiological Association 76 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/11/dyu225.PMC4339762.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/45/awu344.PMC4339768.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/04/awu378.PMC4339771.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/6d/awu381.PMC4339773.pdf
Available from: https://www.jiscmail.,Non-OADS,/arxiv_data1/oa_pdf/62/6d/awu381.PMC4339773.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/ac/awu393.PMC4339775.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jcnur.,Non-OADS,/arxiv_data1/oa_pdf/58/86/jocn0024-0546.PMC4339873.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/eb/8d/ncomms7313.PMC4339883.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Chatterjee, U. et al.",Non-OADS,/arxiv_data1/oa_pdf/eb/8d/ncomms7313.PMC4339883.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7313 ARTICLE NATURE COMMUNICATIONS | 6:6313 | DOI: 10.1038/ncomms7313 | www.nature.com/naturecommunications 7 &2015 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/eb/8d/ncomms7313.PMC4339883.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/c7/6c/ncomms7261.PMC4339914.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Francis, M. F. et al.",Non-OADS,/arxiv_data1/oa_pdf/c7/6c/ncomms7261.PMC4339914.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7261 ARTICLE NATURE COMMUNICATIONS | 6:6261 | DOI: 10.1038/ncomms7261 | www.nature.com/naturecommunications 7 &2015 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/c7/6c/ncomms7261.PMC4339914.pdf
Available from: http://www.who.int/bloodsafety/quality/external_assessment/immunohaematology/en.,Non-OADS,/arxiv_data1/oa_pdf/91/8a/AJTS-9-74.PMC4339938.pdf
(Cell Mol Gastroenterol Hepatol 2015;1:75 –86; http://dx.doi.org/10.1016/j.jcmgh.2014.11.002 ) Keywords: Gallstone Pancreatitis; Mouse Model; Neurogenic Inﬂammation; Secretagogue; Vanilloid.Neurogenic in ﬂammation is caused by the local release of in ﬂammatory neuropeptides such as substance P and calcitonin gene-related peptide from afferent sensory neurons.,Non-OADS,/arxiv_data1/oa_pdf/d7/99/main.PMC4339953.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d7/99/main.PMC4339953.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2014.11.002,OADS,/arxiv_data1/oa_pdf/d7/99/main.PMC4339953.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/c1/main.PMC4339954.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2014.11.004,OADS,/arxiv_data1/oa_pdf/73/c1/main.PMC4339954.pdf
Available at: http://www.oecd.org/els/family/48822253.pdf (last accessed 23March 2013).,Non-OADS,/arxiv_data1/oa_pdf/21/2d/cch0041-0266.PMC4340039.pdf
Available at:http://www.aifs.gov.au/growingup/pubs/techpapers/tp1/pdf.,Non-OADS,/arxiv_data1/oa_pdf/21/2d/cch0041-0266.PMC4340039.pdf
"A template letter and operationalguidance is available at: https://www.gov.uk/government/publications/national-child-measurement-programme-operational-guidance-for-the-2013-to-2014-school-year (accessed29 October, 2013).",Non-OADS,/arxiv_data1/oa_pdf/17/39/jhn0028-0047.PMC4340048.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/2b/nihms662548.PMC4340068.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.ypmed.2014.08.037 .,OADS,/arxiv_data1/oa_pdf/46/2b/nihms662548.PMC4340068.pdf
"Available from: http://www.statcan.gc.ca/pub/11-522-x/2006001/article/10444- eng.pdf Borland R, Yong HH, King B, et al.",OADS,/arxiv_data1/oa_pdf/46/2b/nihms662548.PMC4340068.pdf
"Last Updated April  17, 2012Available from: http://www.competitionbureau.gc.ca/eic/site/cb-bc.nsf/eng/02229.html Canada Gazette.",Non-OADS,/arxiv_data1/oa_pdf/46/2b/nihms662548.PMC4340068.pdf
"Available at: http://www.gazette.gc.ca/rp-pr/ p2/2011/2011-10-12/html/sor-dors178-eng.html Connolly GN, Alpert HR.",Non-OADS,/arxiv_data1/oa_pdf/46/2b/nihms662548.PMC4340068.pdf
"Available from: http://www.who.int/tobacco/surveillance/ en_tfi_gats_2010_brazil.pdf  [accessed 2013 May 22] King B, Borland R. What was “light” and “ mild” is now “smooth” and “fine” new labelling of  Australian cigarettes.",Non-OADS,/arxiv_data1/oa_pdf/46/2b/nihms662548.PMC4340068.pdf
"Available  from: http://news.yahoo.com/zealand-plans-logo-free-cigarette-packs-032216244-finance.html )  [accessed 2013 May 22] Phillips BJ, McQuarrie EF.",Non-OADS,/arxiv_data1/oa_pdf/46/2b/nihms662548.PMC4340068.pdf
"Available from: http://apps.who.int/iris/ bitstream/10665/80510/1/9789241505185_eng.pdf Yong HH, Borland R, Cummings KM, et al.",OADS,/arxiv_data1/oa_pdf/46/2b/nihms662548.PMC4340068.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2014.10.008 2352-2895/ ©2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Neurobiology of Stress 1 (2015) 174 e183,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/22371048 .,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 15555683 .,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 23123920 .,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/21357682 .,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.sciencedirect.com/science/ article/pii/S0306453099000359 (accessed 12.08.14.).,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Avail- able at: http://www.ncbi.nlm.nih.gov/pubmed/24629537 .,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 12511868 .,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/8637635 .,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/23045648 .,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at:http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid ¼2443697 &tool ¼pmcentrez &rendertype ¼abstract .,OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.pubmedcentral.,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 10457187 .,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
Available at: http://www.ncbi.nlm.nih.gov/pubmed/24866043 .B.S.,Non-OADS,/arxiv_data1/oa_pdf/c2/55/main.PMC4340078.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/76/71/main.PMC4340080.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals .elsevier.com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2014.09.005 2352-2895/ ©2014 The Author.,Non-OADS,/arxiv_data1/oa_pdf/76/71/main.PMC4340080.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Neurobiology of Stress 1 (2015) 60 e65,Non-OADS,/arxiv_data1/oa_pdf/76/71/main.PMC4340080.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/5c/main.PMC4340082.pdf
http://dx.doi.org/10.1016/j.gdata.2014.11.006 2213-5960/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/46/5c/main.PMC4340082.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/46/5c/main.PMC4340082.pdf
Contents lists available at ScienceDirect Genomics Data journal homepage: http://www.journa ls.elsevier.com/genomics-data/,Non-OADS,/arxiv_data1/oa_pdf/46/5c/main.PMC4340082.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/54/mzu098.PMC4340271.pdf
2014. p. http://www0.health.,Non-OADS,/arxiv_data1/oa_pdf/bd/54/mzu098.PMC4340271.pdf
"http://www.riskman.net.au/ (19 December 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/bd/54/mzu098.PMC4340271.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/0e/hyu205.PMC4340275.pdf
"Detailsare searchable at the following address: http://www.clinicaltrials.jp/ user/cteSearch.jsp .Jpn J Clin Oncol , 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/5f/0e/hyu205.PMC4340275.pdf
"Available from: http://www.iarc.fr/en/media- centre/iarcnews/2010/globocan2008.php (6 October 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/5f/0e/hyu205.PMC4340275.pdf
"Available from: http://ganjoho.jp/pro/statistics/en/ backnumber/2013_en.html (6 October 2014, date last accessed).",OADS,/arxiv_data1/oa_pdf/5f/0e/hyu205.PMC4340275.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/b9/fdu018.PMC4340323.pdf
"http://www.who.int/dietphysicalactivity/factsheet_inactivity/en/index.html (June 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/37/b9/fdu018.PMC4340323.pdf
"http://news.bbc.co.uk/sport1/hi/tv_and_radio/sports_personality_of_the_year/7735134.stm (June 2013, date last accessed).56 JOURNAL OF PUBLIC HEALTH",Non-OADS,/arxiv_data1/oa_pdf/37/b9/fdu018.PMC4340323.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/ceg-8-101.PMC4340328.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 101–109Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  101REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S5815 3iBS-like symptoms in patients with ulcerative colitis David J Gracie1 Alexander C Ford1,2 1Leeds Gastroenterology institute,    St James’s University Hospital,    2Leeds institute of Biomedical   and Clinical Sciences, University   of Leeds, Leeds, UK Correspondence: Alexander C Ford   Leeds Gastroenterology institute,   Room 125, 4th Floor, Bexley wing,   St James’s University Hospital, Beckett  Street, Leeds LS9 7TF, UK   Tel +44 113 268 4963   Fax +44 113 242 9722   Email alexf12399@yahoo.co mAbstract:  Ulcerative colitis (UC) and irri table  bowel syndrome (IBS) are chronic gastroin - testinal disorders that, until recently, have been considered dichotomous conditions falling on  either side of a functional-organic divide.",Non-OADS,/arxiv_data1/oa_pdf/a1/3b/ceg-8-101.PMC4340328.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/a1/3b/ceg-8-101.PMC4340328.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a1/3b/ceg-8-101.PMC4340328.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/1f/dddt-9-1185.PMC4340329.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1185–1191Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1185Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7575 2electrochemotherapy in combination with  chemoradiotherapy in the treatment of oral  carcinomas in advanced stages of disease: efficacy,  safety, and clinical outcomes in a small number  of selected cases rossana Domanico1 serena Trapasso1 Mariaquila santoro2 Domenico Pingitore2 eugenia allegra1 1Division of Otolaryngology – head  and neck surgery, Department  of Medical and surgical sciences,   University Magna graecia  of catanzaro, catanzaro, italy;  2Division of radiation Oncology  and radiobiology, Department  of hematology, Oncology and  Transfusion Medicine, Pugliese– ciaccio hospital, catanzaro, italyIntroduction:  Electrochemotherapy (ECT) is a new therapeutic method that is used in oncology  as palliative treatment in patients with recurrent head and neck tumors and who are not candi - dates for standard therapeutic options.",Non-OADS,/arxiv_data1/oa_pdf/ee/1f/dddt-9-1185.PMC4340329.pdf
"Through correspondence: eugenia allegra Division of Otolaryngology – head and  neck surgery, Department of Medical  and surgical sciences, University Magna  graecia of catanzaro, italy Viale europa,  germaneto 88100 – catanzaro, italy Tel +39 0961 3647130 Fax +39 0961 3647131 email eualle@unicz.i t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Domanico et al Running head recto: Treating advanced oral carcinomas with ECT and chemoradiotherapy DOI: http://dx.doi.org/10.2147/DDDT.S75752",Non-OADS,/arxiv_data1/oa_pdf/ee/1f/dddt-9-1185.PMC4340329.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ee/1f/dddt-9-1185.PMC4340329.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/1f/dddt-9-1185.PMC4340329.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/72/ceg-8-095.PMC4340330.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical and Experimental Gastroenterology 2015:8 95–100Clinical and Experimental Gastroenterology Dove press submit your manuscript | www.dovepress.co m Dove press  95OriG inal rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEG.S7944 9a pilot trial on subjects with lactose and/or  oligosaccharides intolerance treated with   a fixed mixture of pure and enteric-coated   α- and β-galactosidase Francesco Di Pierro1 alexander Bertuccioli2 Eleonora Marini3 leandro ivaldi4 1Velleja research, Milan, italy;  2italian  association Fitness and Medicine,  Fano, PU, italy;  3Pharmextracta,  Pontenure, Piacenza, italy;  4Digestive  Endoscopic Department, Ceva  hospital, Ceva, Cuneo, italy Correspondence: Francesco Di Pierro   Velleja research, Viale lunigiana  23,  Milano, italy   Tel +39 3495 527663   Fax +39 0523 511894   Email f.dipierro@vellejaresearch.co mAim:  Lactose and complex carbohydrates maldigestion, common food intolerances due to low  gut content of α- and β-galactosidase, lead to abdominal symptoms including pain, diarrhea,  bloating, flatulence, and cramping.",Non-OADS,/arxiv_data1/oa_pdf/b5/72/ceg-8-095.PMC4340330.pdf
"Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-and-experimental-gastroenterology-journa lClinical and Experimental Gastroenterology is an international, peer- reviewed, open access journal, publishing all aspects of gastroenterology  in the clinic and laboratory, including: Pathology, pathophysiology  of gastrointestinal disease; Investigation and treatment of gastointes - tinal disease; Pharmacology of drugs used in the alimentary tract; Immunology/genetics/genomics related to gastrointestinal disease.",Non-OADS,/arxiv_data1/oa_pdf/b5/72/ceg-8-095.PMC4340330.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/72/ceg-8-095.PMC4340330.pdf
311; available at http://www.who.int/ mediacentre/factsheets/fs311/en/index.html World Health Organization (Date of access:14/08/2014).2.,Non-OADS,/arxiv_data1/oa_pdf/aa/48/srep06620.PMC4340361.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 4 : 6620 | DOI: 10.1038/srep06620 7",Non-OADS,/arxiv_data1/oa_pdf/aa/48/srep06620.PMC4340361.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercialreproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/c4/jiu508.PMC4340366.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/2c/ndt-11-385.PMC4340368.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 385–394Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  385Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S6166 5The clinical basis of orthorexia nervosa:  emerging perspectives Correspondence: Nancy S Koven Department of Psychology, Bates  College, 4 Andrews Road, Lewiston,  Me 04240, USA Tel +1 207 786 6426 Fax +1 207 786 8338 email nkoven@bates.ed u Nancy S Koven Alexandra w Abry Department of Psychology, Bates  College, Lewiston, M e, USAAbstract:  Orthorexia nervosa describes a pathological obsession with proper nutrition that is  characterized by a restrictive diet, ritualized patterns of eating, and rigid avoidance of foods  believed to be unhealthy or impure.",Non-OADS,/arxiv_data1/oa_pdf/e8/2c/ndt-11-385.PMC4340368.pdf
We also  highlight what remains unknown about this problematic eating pattern and suggest  multiple avenues for additional research.Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Koven and Abry Running head recto: Clinical basis of orthorexia DOI: http://dx.doi.org/10.2147/NDT.S61665,Non-OADS,/arxiv_data1/oa_pdf/e8/2c/ndt-11-385.PMC4340368.pdf
Avail - able from: http://hdl.handle.net/10355/1120 0.,Non-OADS,/arxiv_data1/oa_pdf/e8/2c/ndt-11-385.PMC4340368.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/e8/2c/ndt-11-385.PMC4340368.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/2c/ndt-11-385.PMC4340368.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/f2/btt-9-023.PMC4340369.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pBiologics: Targets and Therapy 2015:9 23–24Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  23LeTTeropen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/BTT .S7950 7response to Miller et al: resistant mutations   in CML and Ph( +) ALL – role of ponatinib Nathalie Bardy-Bouxin ewa Matczak Geeta Devgan Mabel Woloj Mark Shapiro Pfizer Oncology, Pfizer Inc.,    New Y ork, NY, USA Correspondence: Mark Shapiro   Pfizer Oncology, Pfizer Inc.   10 Fawcett Street, Suite 203   Cambridge, MA 02138, USA   email mark.shapiro1@pfizer.co mDear editor Miller et al1 recently reviewed the role of ponatinib in chronic myeloid leukemia (CML)  and Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph + ALL),  yet by the omission of an approved agent within the same class of drugs, provided an  inaccurate summary of the current treatment landscape for CML.",Non-OADS,/arxiv_data1/oa_pdf/61/f2/btt-9-023.PMC4340369.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/61/f2/btt-9-023.PMC4340369.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/61/f2/btt-9-023.PMC4340369.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/hiv-7-065.PMC4340370.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pHIV/AIDS – Research and Palliative Care 2015:7 65–73HIV/AIDS – Research and Palliative Care Dove press submit your manuscript | www.dovepress.co m Dove press  65ORIg InAl ReSeARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S6669 5l-carnitine supplementation in patients   with HIV/AIDS and fatigue: a double-blind,  placebo-controlled pilot study Ricardo A Cruciani1 Manuel Revuelta2 ella Dvorkin3 Peter Homel4 Pauline lesage5 nora esteban-Cruciani6 1Center for Comprehensive Pain  Management and Palliative Care,   Capital Institute for neurosciences,   Capital Health Medical Center,   Pennington, nJ, 2lee Memorial  Hospital, Fort Myers, Fl,  3Institutional  Review Board, new Y ork University,   new Y ork, nY, 4Department of Pain  Medicine and Palliative Care, Beth  Israel Medical Center, new Y ork,   nY, 5Maimonides Medical Center,   Brooklyn, nY, 6Children’s Hospital at  Montefiore, Albert einstein College   of Medicine, Bronx, nY, USA Correspondence: Ricardo A Cruciani   Center for Comprehensive Pain  Management and Palliative Care,   2 Capital Way, Suite  456,   Capital Institute for neurosciences,  Capital Health Medical Center,   Pennington, nJ  08534, USA   Tel +1 609 537 7300  Fax +1 609 537 7301  email rcruciani@capitalhealth.or gBackground:  The purpose of this study was to determine the effect of L-carnitine  supplementation on fatigue in patients with terminal human immunodeficiency virus/acquired  immune deficiency syndrome (HIV/AIDS).",Non-OADS,/arxiv_data1/oa_pdf/69/e9/hiv-7-065.PMC4340370.pdf
Available from  http://www.questdiagnostics.com/testcenter/BUOrderInfo.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/hiv-7-065.PMC4340370.pdf
"HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/hivaids---research-and-palliative-care-journa lHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open-access journal focusing on advances in research in HIV ,  its clinical progression and management options including antiviral  treatment, palliative care and public healthcare policies to control  viral spread.",Non-OADS,/arxiv_data1/oa_pdf/69/e9/hiv-7-065.PMC4340370.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/e9/hiv-7-065.PMC4340370.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d8/84/jbm-6-055.PMC4340371.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 55–67Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  55Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JBM.S5278 3Hematopoietic stem and progenitor cell  harvesting: technical advances and clinical utility Olivier Hequet1,2 1etablissement Français du Sang  Rhône Alpes, Apheresis Unit, Centre  Hospitalier Lyon Sud France, 2Cell  Therapy Unit, etablissement Français  du Sang (eFS) Rhône-Alpes, Hospital  edouard Herriot, Lyon, France Correspondence: Olivier Hequet   Banque de tissus et de cellules,  etablissement Français du Sang (eFS),  Pavillon i, Hospital edouard Herriot,   5 Place d’Arsonval, 69003 Lyon, France   Tel +33 4 7268 4620   Fax +33 4 7268 4621   email olivier.hequet@efs.sante.f rAbstract:  Hematopoietic stem and progenitor cell (HSPC) transplantations require prior  harvesting of allogeneic or autologous HSPCs.",Non-OADS,/arxiv_data1/oa_pdf/d8/84/jbm-6-055.PMC4340371.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/d8/84/jbm-6-055.PMC4340371.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/84/jbm-6-055.PMC4340371.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/44/84/jmdh-8-109.PMC4340372.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 109–115Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  109Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S4980 5The multidisciplinary management of bone   and soft tissue sarcoma: an essential  organizational framework Geoffrey w Siegel1 J Sybil Biermann1 Rashmi Chugh2 Jon A Jacobson3 David Lucas4 Mary Feng5 Andrew C Chang6 Sean R Smith7 Sandra L wong6 Jill Hasen1 1Department of Orthopedics,   2Department of Medical Oncology,   3Department of Radiology,   4Department of Pathology,   5Department of Radiation,   6Department of Surgery,   7Department  of Physical Medicine  and Rehabilitation, University of  Michigan, Ann Arbor, M i, USA Correspondence: J Sybil Biermann   Department of Orthopedics, University  of Michigan, Cancer Center Floor B1  Reception C, 1500 e Medical Center   Dr SPC 5912, Ann Arbor, Mi 48109, USA   Tel +1 734 647 8902   Fax +1 734 647 8672   email biermann@med.umich.ed uAbstract:  The rarity of bone and soft tissue sarcoma, the difficulty in interpretation of imag - ing and histology, the plethora of treatment modalities, and the complexity and intensity of  the treatment contribute to the need for systematic multidisciplinary team management of  patients with these diseases.",Non-OADS,/arxiv_data1/oa_pdf/44/84/jmdh-8-109.PMC4340372.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/44/84/jmdh-8-109.PMC4340372.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/44/84/jmdh-8-109.PMC4340372.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/ca/ijwh-7-239.PMC4340373.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 239–242International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  239RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S7516 4Health education during antenatal care: the need  for more Mohammed A Al-Ateeq1 Amal A Al-Rusaiess2 1College of Medicine, King Saud Bin  Abdul-Aziz University for Health  Sciences, 2Department of Family  Medicine and Primary Health Care,   King Abdul-Aziz Medical City,   National Guard Health Affairs, Riyadh,   Kingdom of Saudi ArabiaAbstract:  The aim of health education during antenatal is to provide advice, education,   reassurance and support, to address and treat the minor problems of pregnancy, and to provide  effective screening during the pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/aa/ca/ijwh-7-239.PMC4340373.pdf
"In light of this, recent recommen - dations for ANC stress the need to address both the psychosocial and medical needs  of women,7 as well as the concept of the new ANC model, as promoted by the World  Health Organization (WHO), reflects the new understanding of the role of ANC.8 World Health Report 2005 calls for “realizing the Potential of Antenatal Care.”9  While ANC interventions, in and of themselves, cannot be expected to have a major  impact on maternal mortality, their purpose is to improve maternal and perinatal  health.10 In addition, the potential of ANC as a line of action to increase the rate of  births attended by skilled health staff, and its value as entry point for other health  programs such as nutrition, is now better understood and applied.9–12 Each of the ANC visits consists of a well-defined set of activities related to three  equally important general areas, namely screening for conditions likely to increase  adverse outcomes, providing therapeutic interventions known to be beneficial, and  educating pregnant women about planning for a safe birth, emergencies during preg - nancy, and how to deal with them.8Correspondence: Mohammed A Al-Ateeq Department of Family Medicine and PHC,  King Abdul-Aziz Medical City, National  Guard Health Affairs, Riyadh, Kingdom  of Saudi Arabia Tel +966 11 801 111 ext 46585, 46583,  49187 Mobile +966 505 159 741 email malateeq@hotmail.co m Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Al-Ateeq and Al-Rusaiess Running head recto: Improving antenatal health care education DOI: http://dx.doi.org/10.2147/IJWH.S75164",Non-OADS,/arxiv_data1/oa_pdf/aa/ca/ijwh-7-239.PMC4340373.pdf
"This review was completed during the preparation  for the research titled “Perceptions and effects of antenatal  education,” a cross-sectional study, which is available from  http://www.ncbi.nlm.nih.gov/pubmed/2434347 0.",Non-OADS,/arxiv_data1/oa_pdf/aa/ca/ijwh-7-239.PMC4340373.pdf
Available from: http://www.euro.who.,Non-OADS,/arxiv_data1/oa_pdf/aa/ca/ijwh-7-239.PMC4340373.pdf
"Available from: http://www.who.int/whr/2005/whr2005_en.pd f  10. WHO, UNICEF.",Non-OADS,/arxiv_data1/oa_pdf/aa/ca/ijwh-7-239.PMC4340373.pdf
Available from: http://www.childinfo.org/files/antenatal_care.pd f  11.,Non-OADS,/arxiv_data1/oa_pdf/aa/ca/ijwh-7-239.PMC4340373.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/aa/ca/ijwh-7-239.PMC4340373.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/aa/ca/ijwh-7-239.PMC4340373.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/7e/ijgm-8-079.PMC4340374.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:9 79–86International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  79OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S7045 6Prophylactic onabotulinumtoxina in patients  with chronic migraine and comorbid depression:  An open-label, multicenter, pilot study of efficacy,  safety and effect on headache-related disability,  depression, and anxiety Guy P Boudreau1 Brian M Grosberg2 Peter J Mcallister3 richard B lipton2 Dawn c Buse2 1clinique de la Migraine et céphalées,   Département de neurologie,   centre hospitalier de l’Université  de Montréal, hôpital notre- Dame, Montreal, Qc , canada;   2Montefiore headache center and  the Department of neurology, albert  einstein college of Medicine, Bronx,   nY, Usa; 3new england Institute for  neurology and headache, stamford,   and The Frank h netter school of  Medicine at Quinnipiac University,   hamden, cT, Usa correspondence: Guy P Boudreau   clinique de la Migraine et céphalées,  Département de neurologie, centre  hospitalier de l’Université de Montréal,  hôpital notre-Dame, 1560 rue  sherbrooke est, Montréal, Quebec,   h2l 4M1, canada   Tel +1 514 890 8000   Fax +1 514 412 7711   email guypboudreau@gmail.co mBackground:  Chronic migraine is associated with significant headache-related disability and  psychiatric comorbidity.",Non-OADS,/arxiv_data1/oa_pdf/65/7e/ijgm-8-079.PMC4340374.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/65/7e/ijgm-8-079.PMC4340374.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/7e/ijgm-8-079.PMC4340374.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/7b/ijn-10-1479.PMC4340375.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1479–1492International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1479OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7415 8Internalization and fate of silica nanoparticles  in c2c12 skeletal muscle cells: evidence  of a beneficial effect on myoblast fusion Sylvie Poussard1,2 Marion Decossas1,2 Olivier le Bihan1,2 stéphane Mornet3 grégoire Naudin1,2 Olivier lambert1,2 1Institute of Chemistry  and Biology  of Membranes and Nanoobjects,   University  of Bordeaux,  UMR5248,   Pessac, France; 2Institute  of Chemistry   and Biology of Membranes  and  Nanoobjects, centre National de la  recherche scientifique, Institute of  Chemistry  and Biology of Membranes   and Nanoobjects,  UMR5248,  Pessac,  France; 3IcMcB, Institut de chimie de  la Matière condensée de Bordeaux,   CNRS UPR9048,  Université  de  Bordeaux,  Pessac, FranceAbstract:  The use of silica nanoparticles for their cellular uptake capability opens up new  fields in biomedical research.",Non-OADS,/arxiv_data1/oa_pdf/04/7b/ijn-10-1479.PMC4340375.pdf
"Beneficial treatments correspondence: Olivier lambert Institute of Chemistry and Biology of  Membranes and Nanoobjects, UMR5248,  University Bordeaux, Allée Geoffroy  Saint-Hilaire 33600 Pessac, France Tel +33 54000 6829 Fax +33 54000 2200 email o.lambert@cbmn.u-bordeaux.f r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Poussard et al Running head recto: Internalization of silica nanoparticles in muscle cells DOI: http://dx.doi.org/10.2147/IJN.S74158",Non-OADS,/arxiv_data1/oa_pdf/04/7b/ijn-10-1479.PMC4340375.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/04/7b/ijn-10-1479.PMC4340375.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/7b/ijn-10-1479.PMC4340375.pdf
Anatomy and Histology of the Small and Large  Intestine  http://jpck.zju.edu.cn/jcyxjp/files/ge/   05/MT/0511.pdf   13.,Non-OADS,/arxiv_data1/oa_pdf/64/69/CHSJ-40-3-153.PMC4340434.pdf
2005  (downloadable free from http://www.wma.net)   7.,Non-OADS,/arxiv_data1/oa_pdf/f8/78/CHSJ-40-3-162.PMC4340435.pdf
"EUCAST - Clinical breakpoints  – bacteria, v.3.1;  http://www.eucast.org/fileadmin/src/media/PDFs/E UCAST_files/Breakpoint_tables/Breakpoint_table_ v_3.1.pdf 2013.",OADS,/arxiv_data1/oa_pdf/a2/e6/CHSJ-40-2-085.PMC4340447.pdf
http://www.ndhealth.gov/microlab/Uploads/Hodge Test.pdf .,Non-OADS,/arxiv_data1/oa_pdf/a2/e6/CHSJ-40-2-085.PMC4340447.pdf
http://www.who.int/drugresistance/whonetsoftware /en/ .,OADS,/arxiv_data1/oa_pdf/a2/e6/CHSJ-40-2-085.PMC4340447.pdf
Available from:  http://www.ncbi.nlm.nih.gov/books/NBK19960/    16.,Non-OADS,/arxiv_data1/oa_pdf/cf/45/CHSJ-40-2-097.PMC4340449.pdf
"Press release , 2007, a vailable at  http://www.alriyadh.com/200702/18/article225849.",Non-OADS,/arxiv_data1/oa_pdf/cf/45/CHSJ-40-2-097.PMC4340449.pdf
"Retrieved from   http://www.mindtools.com/mnemlstylo.htm     Corresponding Author: Buşan Alina -Mihaela, student,  Faculty of Medicine, University of Medicine and  Pharmacy of Craiova, 2-4 Petru R ares St, Craiova 200349, Romania   110 DOI: 10.12865/CHSJ.40.02.04",Non-OADS,/arxiv_data1/oa_pdf/06/f8/CHSJ-40-2-104.PMC4340450.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ndt-11-379.PMC4340459.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 379–384Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  379OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7496 6One-year follow-up in patients with brainstem  infarction due to large-artery atherothrombosis Mehmet Kolukısa1 T ugce Ozdemir gültekin1 gozde eryigit Baran1 ayse aralasmak2 gülsen Kocaman1 azize esra gürsoy1 Talip asil1 1Department of Neurology,   2Department of radiology, Faculty  of Medicine, Bezmialem Vakıf  University, istanbul, T urkeyBackground:  Posterior circulation infarction accounts for approximately 25% of the ischemic  strokes.",Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ndt-11-379.PMC4340459.pdf
"On the other hand, in patients with brainstem infarction who have  large-arterial atherothrombosis, there is a relative lack of information on therapeutic  options regardless of the presence of extracranial or intracranial arterial stenosis.4 correspondence: Talip asil Department of Neurology, Faculty  of Medicine, Bezmialem Vakıf University,  Vatan cad 34093, istanbul, Turkey Tel +9021 2453 1700 email talip_asil©yahoo.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kolukısa et al Running head recto: Follow-up in patients with brainstem infarctions DOI: http://dx.doi.org/10.2147/NDT.S74966",Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ndt-11-379.PMC4340459.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ndt-11-379.PMC4340459.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/7f/ndt-11-379.PMC4340459.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/5e/idr-8-019.PMC4340460.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 19–29Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  19RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S5870 6The role of dolutegravir in the management   of HIv infection Misty M Miller1 Michelle D Liedtke1 Staci M Lockhart2 R Chris Rathbun1 1Department of Pharmacy: Clinical  and Administrative Sciences,   University of Oklahoma College of  Pharmacy, Oklahoma City, OK, USA;   2Abbvie Inc., Oklahoma City, OK, USA Correspondence: Misty M Miller   Department of Pharmacy: Clinical and  Administrative Sciences, University  of Oklahoma College of Pharmacy,  1110 North Stonewall Ave, CPB 205,  Oklahoma City, OK 73117, USA   Tel +1 405 271 6878 (ext 47029)   Fax +1 405 271 6430   email misty-miller@ouhsc.ed uAbstract:  Dolutegravir is the most recent integrase strand transfer inhibitor approved for HIV -1  infection in both treatment-naïve and experienced patients.",Non-OADS,/arxiv_data1/oa_pdf/9d/5e/idr-8-019.PMC4340460.pdf
"Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/Adultand   AdolescentGL.pd f. Updated May 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/9d/5e/idr-8-019.PMC4340460.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT0196855 1.,Non-OADS,/arxiv_data1/oa_pdf/9d/5e/idr-8-019.PMC4340460.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT0181573 6.,Non-OADS,/arxiv_data1/oa_pdf/9d/5e/idr-8-019.PMC4340460.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT0212179 5.,Non-OADS,/arxiv_data1/oa_pdf/9d/5e/idr-8-019.PMC4340460.pdf
Available from:  http://clinicaltrials.gov/ct2/show/NCT0164180 9.,Non-OADS,/arxiv_data1/oa_pdf/9d/5e/idr-8-019.PMC4340460.pdf
Available from: http://clinicaltrials.gov/ ct2/show/NCT0212035 2.,Non-OADS,/arxiv_data1/oa_pdf/9d/5e/idr-8-019.PMC4340460.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/document_ library/EPAR_-_Product_Information/human/002753/WC500160680.,Non-OADS,/arxiv_data1/oa_pdf/9d/5e/idr-8-019.PMC4340460.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/9d/5e/idr-8-019.PMC4340460.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/5e/idr-8-019.PMC4340460.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2b/bd/ibpc-8-001.PMC4340461.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pIntegrated Blood Pressure Control 2015:8 1–6Integrated Blood Pressure Control Dove press submit your manuscript | www.dovepress.co m Dove press  1OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IBPC.S6845 4nitric oxide dysregulation in the pathogenesis   of preeclampsia among ghanaian women Kwame adu-Bonsaffoh1,2 Daniel ansong antwi1 samuel amenyi Obed3 Ben gyan4 1Department of Physiology, University  of ghana Medical school, accra,   ghana;  2Department of Obstetrics  and gynecology, Korle Bu T eaching  hospital, accra, ghana; 3Department  of Obstetrics and gynecology,   University of ghana Medical school,   accra, ghana; 4Department of  Immunology, noguchi Memorial  Institute for Medical research,   University of ghana, accra, ghana Correspondence: Kwame adu-Bonsaffoh   Department of Obstetrics and  gynecology, Korle Bu Teaching hospital,  PO box KB783, Korle Bu, accra, ghana   Tel +233 20 630 0840  email bonsaffoh@yahoo.co mBackground:  Preeclampsia (PE) is still a disease of theories as the exact cause remains  uncertain.",Non-OADS,/arxiv_data1/oa_pdf/2b/bd/ibpc-8-001.PMC4340461.pdf
"Integrated Blood Pressure Control Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/integrated-blood-pressure-control-journa lIntegrated Blood Pressure Control is an international, peer-reviewed  open-access journal focusing on the integrated approach to managing  hypertension and risk reduction.",Non-OADS,/arxiv_data1/oa_pdf/2b/bd/ibpc-8-001.PMC4340461.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2b/bd/ibpc-8-001.PMC4340461.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b4/d3/oajsm-6-037.PMC4340462.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 37–48Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  37Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S7534 5Bone bruises in anterior cruciate ligament   injured knee and long-term outcomes.,Non-OADS,/arxiv_data1/oa_pdf/b4/d3/oajsm-6-037.PMC4340462.pdf
"Methods For article research, the PubMed online database was used  (http://www.ncbi.nlm.nih.gov/pubmed ).",OADS,/arxiv_data1/oa_pdf/b4/d3/oajsm-6-037.PMC4340462.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/b4/d3/oajsm-6-037.PMC4340462.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b4/d3/oajsm-6-037.PMC4340462.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9a/d6/ijn-10-1449.PMC4340463.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1449–1462International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1449OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7613 4Cell type-specific response to high intracellular  loading of polyacrylic acid-coated magnetic  nanoparticles Jasna lojk1 Vladimir B Bregar1 Maruša Rajh1 Katarina Miš2 Mateja erdani Kreft3 Sergej Pirkmajer2 Peter Veranič3 Mojca Pavlin1 1Group for Nano and Biotechnological  applications, Faculty of electrical  Engineering, 2Institute of  Pathophysiology, Faculty of Medicine,  3Institute of Cell Biology, Faculty of  Medicine, University of ljubljana,  ljubljana, slovenia Abstract:  Magnetic nanoparticles (NPs) are a special type of NP with a ferromagnetic, electron- dense core that enables several applications such as cell tracking, hyperthermia, and magnetic  separation, as well as multimodality.",Non-OADS,/arxiv_data1/oa_pdf/9a/d6/ijn-10-1449.PMC4340463.pdf
"Besides that, NPs have been  shown to improve solubility of the attached cargo, reduce its cytotoxicity, protect it  from degradation or the immune system, and can prolong its circulation half-life.4–7  The desired effects of NPs depend on specific applications, but NPs should generally  be nontoxic, nonimmunogenic, biocompatible, stable, and possibly biodegradable,  most of which can be achieved by careful design of NPs.2,3,8  Due to their small size, sometimes even comparable to regular endocytic cargo,9  most NPs enter the cells through the cell’s innate mechanisms of endocytosis.10 Correspondence: Mojca Pavlin Group for Nano and Biotechnological  applications, Faculty of electrical  Engineering, University of Ljubljana,  Trzaska 25, 1000 ljubljana, slovenia Tel +386 1 476 89 49 Fax +386 1 426 48 50 email mojca.pavlin@fe.uni-lj.s i Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Lojk et al Running head recto: Cell type-specific response to PAA coated nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S76134",Non-OADS,/arxiv_data1/oa_pdf/9a/d6/ijn-10-1449.PMC4340463.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9a/d6/ijn-10-1449.PMC4340463.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/d6/ijn-10-1449.PMC4340463.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/98/vhrm-11-133.PMC4340464.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 133–148Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  133ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S4446 9Platelet function tests: a comparative review Rita Paniccia1,2 Raffaella Priora1,2 Agatina Alessandrello  Liotta2 Rosanna Abbate1,2 1Department of experimental and  Clinical Medicine, Thrombosis Center,   University of Florence, Florence, italy;   2Department of Heart and Vessels,   Azienda Ospedaliero-Universitaria  Careggi, Florence, italy Correspondence: Rita Paniccia   Department of experimental and   Clinical Medicine, Thrombosis Center,  University of Florence, Viale Pieraccini,  19, 50134 Florence, italy   Tel +39 055 7949 419   Fax +39 055 7949 929   email rita.paniccia@unifi.i tAbstract:  In physiological hemostasis a prompt recruitment of platelets on the vessel damage  prevents the bleeding by the rapid formation of a platelet plug.",Non-OADS,/arxiv_data1/oa_pdf/b1/98/vhrm-11-133.PMC4340464.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/b1/98/vhrm-11-133.PMC4340464.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/98/vhrm-11-133.PMC4340464.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/77/f0/prbm-8-063.PMC4340465.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pPsychology Research and Behavior Management 2015:8 63–69Psychology Research and Behavior Management Dove press submit your manuscript | www.dovepress.co m Dove press  63Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PRBM.S5226 7The evolution of cognitive–behavioral therapy   for psychosis Helen Mander David Kingdon Mental Health Group, University  of Southampton, Southampton,   Hampshire, england, UK Correspondence: David Kingdon   University of Southampton,   College Keep, 4-12 Terminus   Terrace, Southampton SO14 3DT,  Hampshire, england, UK   email dgk@soton.ac.u kAbstract:  Cognitive therapy for psychosis has developed over the past 30 years from initial  case studies, treatment manuals, pilot randomized controlled studies to fully powered and  methodologically rigorous efficacy and, subsequently, effectiveness trials.",Non-OADS,/arxiv_data1/oa_pdf/77/f0/prbm-8-063.PMC4340465.pdf
"Psychology Research and Behavior Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/psychology-research-and-behavior-management-journa lPsychology Research and Behavior Management is an international, peer- reviewed, open access journal focusing on the science of psychology and  its application in behavior management to develop improved outcomes  in the clinical, educational, sports and business arenas.",Non-OADS,/arxiv_data1/oa_pdf/77/f0/prbm-8-063.PMC4340465.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/77/f0/prbm-8-063.PMC4340465.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/aa/cmar-7-075.PMC4340466.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 75–82Cancer Management and Research Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/41/aa/cmar-7-075.PMC4340466.pdf
"Or use: http://dvpr.es/1uRSLH zDove press submit your manuscript | www.dovepress.co m Dove press  75Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S5180 8Afatinib for the treatment of metastatic non-small  cell lung cancer Monika Joshi Syed M Rizvi Chandra P Belani Penn State Milton S Hershey Medical  Center, Department of Medicine,   Division of Hematology-Oncology,   Hershey, PA, USA Correspondence: Monika Joshi   Penn State Milton S Hershey Medical  Center, Penn State College of Medicine,  Department of Medicine, Division of  Hematology-Oncology, Mail Code CH46,  500 University Drive, PO Box 850,  Hershey, PA 17033, USA   Tel +1 717 531 8678   Fax +1 717 531 5076   email mjoshi@hmc.psu.ed uAbstract:  Targeting the epidermal growth factor receptor (EGFR) in patients with non-small  cell lung cancer (NSCLC) harboring sensitizing mutations in the tyrosine kinase (TKI) domain  has led to a significant change in the management of this disease.",Non-OADS,/arxiv_data1/oa_pdf/41/aa/cmar-7-075.PMC4340466.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/41/aa/cmar-7-075.PMC4340466.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/aa/cmar-7-075.PMC4340466.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fb/f6/ijn-10-1359.PMC4340467.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 1359–1373International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  1359OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7749 2Binding of plasma proteins to titanium dioxide  nanotubes with different diameters Correspondence: Aleš Iglič laboratory of Biophysics, Faculty of  electrical engineering, University of  Ljubljana, Tržaška 25, SI-1000 Ljubljana,  slovenia, slovenia  Tel +386 1 4768 235 Fax +386 1 4268 850 email ales.iglic@fe.uni-lj.s i Mukta Kulkarni1,* Ajda Flašker1,* Maruša Lokar1 Katjuša Mrak-Poljšak2 anca Mazare3 Andrej Artenjak4 Saša Čučnik2 Slavko Kralj5 Aljaž Velikonja1 Patrik Schmuki3 Veronika Kralj-Iglič6 Snezna Sodin-Semrl2,7 Aleš Iglič1 1laboratory of Biophysics, Faculty  of electrical engineering, University  of ljubljana, ljubljana, slovenia;   2Department of rheumatology,   University Medical centre  ljubljana,  ljubljana, slovenia;   3Department of Materials science and  engineering, University of erlangen  Nuremberg, erlangen, germany;   4sandoz Biopharmaceuticals Mengeš,   Lek Pharmaceuticals dd, Menges,   slovenia; 5Department for Materials  Synthesis, Institute Jožef Stefan  (IJs), ljubljana, slovenia; 6Faculty  of health studies, University of  ljubljana, ljubljana, slovenia; 7Faculty  of Mathematics, Natural science and  Information Technology, University  of Primorska, Koper, Slovenia  *These authors contributed equally  to this workAbstract:  Titanium and titanium alloys are considered to be one of the most applicable  materials in medical devices because of their suitable properties, most importantly high corrosion  resistance and the specific combination of strength with biocompatibility.",Non-OADS,/arxiv_data1/oa_pdf/fb/f6/ijn-10-1359.PMC4340467.pdf
Surface  physical and chemical Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Kulkarni et al Running head recto: Binding of plasma proteins to titanium dioxide nanotubes  DOI: http://dx.doi.org/10.2147/IJN.S77492,Non-OADS,/arxiv_data1/oa_pdf/fb/f6/ijn-10-1359.PMC4340467.pdf
Available from:  http://isoelectric.ovh.org /.,OADS,/arxiv_data1/oa_pdf/fb/f6/ijn-10-1359.PMC4340467.pdf
"Available  from: http://openwetware.org/wiki/Griffin:Antibody_Basic s. Accessed  November 6, 2014.",OADS,/arxiv_data1/oa_pdf/fb/f6/ijn-10-1359.PMC4340467.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/fb/f6/ijn-10-1359.PMC4340467.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/f6/ijn-10-1359.PMC4340467.pdf
See http://creativecommons.org/licenses/by-nc/2.0/de/Europe PMC Funders Group Author Manuscript Demogr Res .,Non-OADS,/arxiv_data1/oa_pdf/4f/3e/emss-61764.PMC4340557.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/9a/20/main.PMC4340657.pdf
2352-345X http://dx.doi.org/10.1016/j.jcmgh.2014.11.005,OADS,/arxiv_data1/oa_pdf/9a/20/main.PMC4340657.pdf
http://dx.doi.org/10.1111/liv.12685 .,Non-OADS,/arxiv_data1/oa_pdf/9a/20/main.PMC4340657.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/9a/20/main.PMC4340657.pdf
"This Open Access article is distributed under the terms of the Creative Commons License Attribution-Non-Commercial Share Alike (http://creativecommons.org/licenses/by-nc-sa/4.0/).THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT Volume 5, Number 1, 2015Mary Ann Liebert, Inc.DOI: 10.1089/ther.2014.0021 17",Non-OADS,/arxiv_data1/oa_pdf/ef/66/ther.2014.0021.PMC4340806.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-sa/3.0/ 466 BRITISH DENTAL JOURNAL   VOLUME 217  NO.",Non-OADS,/arxiv_data1/oa_pdf/69/c6/sj.bdj.2014.908.PMC4340975.pdf
Availability and implementation: All source code and suggested parameters are available in an un-encapsulated layout on http://wmbedmands.github.io/MetMSLine/.,OADS,/arxiv_data1/oa_pdf/ac/31/btu705.PMC4341062.pdf
"788 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/31/btu705.PMC4341062.pdf
